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A major risk factor for cardiovascular disease (CVD) is elevated low-density lipoprotein
cholesterol (LDL-C). High-density lipoprotein (HDL) functionality can play a role in
reducing risk for CVD by assisting in cholesterol homeostasis. Additionally, high plasma
trimethylamine-N-oxide (TMAO) concentrations are related to increased CVD risk and
increased atherosclerosis progression. Eggs are a rich source of dietary choline, a
precursor for TMAO formation. Therefore, the effects of egg intake in comparison to a
choline bitartrate supplement were explored in a young, healthy population. The aim was
to show the benefits of egg consumption without increasing risk for CVD in young adults.
The hypothesis was that choline from eggs would increase plasma choline concentrations
and would not negatively increase plasma TMAO in comparison to choline bitartrate.

Thirty participants (48% males; 25.6  2.3 years old; body mass index (BMI) 24.3  2.9
kg/m2) consumed 3 eggs per day or choline bitartrate (~400 mg dietary choline in eggs
or supplement) for 4 weeks each in a randomized crossover study, followed by a washout
period and then allocated to the alternate treatment. Anthropometrics data, dietary
records, and blood samples were collected at the end of each interventional arm for
analyses.

Bruno Silva Lemos – University of Connecticut, 2019

When comparing treatments, no change was observed in BMI, waist circumference, blood
pressure, plasma fasting glucose, triglycerides, creatinine, and liver enzymes. Total
cholesterol, LDL-C, and HDL cholesterol (HDL-C) was higher, and C-reactive protein was
lower with egg intake, with no changes in LDL-C/HDL-C ratio. Dietary total fat, cholesterol,
selenium, and vitamin E were higher, and carbohydrates were lower as a result of egg
consumption. For HDL functionality, egg intake resulted in higher apolipoprotein (apo) AI
and E with no changes in apo B or paraoxonase 1 activity. Cholesterol biosynthesis was
down regulated with egg intake at the gene expression level. Fasting plasma choline was
increased with egg intake. Surprisingly, no difference in plasma TMAO was seen with
treatments.

Data suggest that egg intake contributes to choline availability in plasma when comparing
to choline bitartrate supplementation, while the dietary cholesterol regulates the
endogenous synthesis of cholesterol without negatively impacting risk for CVD in young,
healthy individuals.
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Chapter 1: Introduction
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1.1.

Introduction

Cardiovascular disease (CVD) is considered the leading cause of death in the United
States1. Atherosclerosis, the major cause of CVD, is characterized as a continuous lipid
accumulation and inflammatory cells in the intima of large arteries2. This condition is
initiated by the infiltration of the most atherogenic particle, low-density lipoprotein (LDL)3.
When in the intima, LDL can be modified or oxidized, taken up by macrophages, and
result in foam cell formation. If this process persists, the fibrous cap formed becomes
susceptible to rupture, causing clinical manifestations such as acute myocardial infarction
or sudden death2. Many other factors can contribute to the development of
atherosclerosis. Data suggest that modifiable factors such as diet and physical activity
can prevent the risk of CVD1.

With the increasing prevalence of CVD, research has focused on dietary components and
their associations with atherosclerosis progression. Trimethylamine-N-oxide (TMAO) is a
metabolite studied due to its relationship with atherosclerosis risk in humans and
atherosclerosis development in mice4. Dietary nutrients such as choline, carnitine, and
betaine are utilized by the gut microbiota to produce trimethylamine (TMA) 5. When
circulating TMA reaches the liver, it can be oxidized by flavin monooxygenases (FMO) to
TMAO. High concentrations of TMAO in mice have been shown to promote aortic root
atherosclerotic plaque formation5. Consequently, TMAO enhances the expression of
scavenger receptors (CD36 and SR-A1) responsible for the uptake of cholesterol and
foam cell formation in macrophages4. Additionally, high concentrations of TMAO in
plasma are associated with CVD risk in a large human cohort study4 and increase in
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platelet reactivity and thrombosis in healthy individuals 6. Therefore, the increased
awareness about consuming foods high in TMA/TMAO precursors.

Dietary cholesterol has been thought to be a factor for CVD risk. With that, the
consumption of eggs is still dubious to the general population due to its high cholesterol
content. On the other hand, epidemiological data show no correlation between dietary
cholesterol and CVD risk7. Besides, eggs are a great source of high quality protein,
vitamins, minerals, and choline8. Although the Dietary Guidelines for Americans 20152020 removed the daily recommendation for dietary cholesterol9, eggs are still being
targeted due to their choline content (~130 mg per large egg)10. Choline is an essential
nutrient that exerts various functions such as neuron development, homocysteine
metabolism, cell-membrane signaling, and lipid transport11. Nevertheless, Americans do
not meet the adequate intake of daily dietary choline which can lead to choline deficiency
and result in fatty liver12. Therefore, there is an interest in exploring food sources rich in
choline that increase choline intake and bioavailability in plasma without compromising
metabolic functions. While choline is a precursor for TMAO, continuous research is being
done to evaluate different sources of choline and TMAO formation.

Understanding the impact of egg consumption in comparison to another choline source,
such as a choline bitartrate supplement, helps to fill the gap in the literature and further
explore the effects on TMAO formation. Therefore, the following study had the objective
to assess two different sources of choline in the formation of plasma TMAO and
bioavailability of choline. CVD risk biomarkers such as plasma lipids, lipoprotein profile,

3

HDL functionality, gene expression in regard to cholesterol biosynthesis and TMAO
metabolism, and fasting plasma choline and TMAO concentrations, were determined with
the purpose to investigate if eggs can be incorporated into the diet of healthy, young
adults without raising their risk for CVD. The hypothesis was that choline from eggs would
increase plasma choline concentrations and would not negatively increase plasma TMAO
not CVD biomarkers in comparison to choline bitartrate supplement, a free choline form.

4

Chapter 2: Literature Review
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2.1. Cardiovascular Disease and Lipid Metabolism
2.1.1. Atherosclerosis
Living a healthy lifestyle has become a great concern to the general population. With the
increase in prevalence of the leading cause of death in the United States and worldwide,
cardiovascular disease (CVD) is affecting one in every four Americans 13. CVD involves
conditions that affect the heart and blood vessels consequently increasing the risk of
cardiovascular events that include heart attack and failure, stroke, and/or arrhythmia14.
Therefore, the importance to further understand the mechanisms and treatments
associated with CVD as well as to help diminish the continuous rise in death rate.

Atherosclerosis, the major cause of CVD, characterizes by the onset of an inflammatory
state in the arterial wall involving lipids and immune cells 2. The main risk factor for
atherogenesis is the increase in circulating cholesterol-rich lipoproteins, primarily low
density lipoprotein (LDL)15. Briefly, LDL is sequestered by the arterial wall, where it will
undergo modifications such as oxidation 3. Consequently, resident macrophages will
engulf these modified particles forming foam cells and then initiate an acute inflammatory
process, which will involve secretion of pro-inflammatory cytokines that will recruit more
monocytes to the lesion site15. The ongoing formation of foam cells with the release of
growth factors and cytokines will lead to a fatty streak, which will eventually recruit
vascular smooth muscle cells (VSMC) to the intima in order to form a fibrous cap 16. With
the continuous growing of this fibrous cap, the atherosclerotic plaque can rupture due to
weakening of the cap and decrease of VSMCs, resulting in thrombus which can have a
clinical manifestation of myocardial infarction and sudden death 2. The role of LDL in
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atherogenesis and high-density lipoprotein (HDL) in the prevention of atherosclerosis
plaque formation via reverse cholesterol transport (RCT) is extremely important.

2.1.2. Lipoproteins
Lipoproteins carry cholesterol through circulation and play an important role in CVD and
lipid metabolism. Epidemiological studies have shown that high LDL cholesterol (LDL-C)
and low HDL cholesterol (HDL-C) levels are a risk factors for CVD2. Therefore,
understanding lipoprotein metabolism helps elucidate potential therapeutics and
biological targets for emerging pathologies, most specifically atherosclerosis.

Dietary lipids, fat and cholesterol, are absorbed in the small intestine and incorporated
into lipoproteins known as chylomicrons. When dietary fats are in the chylomicrons, they
travel into the lymphatic system, then into circulation where they deliver lipids to
extrahepatic tissues, primarily adipose tissue. By the action of lipoprotein lipase (LPL),
lipids are delivered to these tissues and eventually chylomicrons will transform into
chylomicron remnants17. Then, hepatocytes recognize chylomicron remnants due to the
presence of apo E in these particles and they are taken by the liver either by the LDL
receptor (LDLR) or LRP, which recognize apo E. The lipid content from chylomicron
remnants within the liver cells along with endogenous lipids form very low-density
lipoprotein (VLDL) particles containing apo B-100 which will be secreted into circulation.
These particles deliver its content to adipose tissue, muscle and other tissues through the
action of LPL, and then an intermediate density lipoprotein is formed18. After further
processing and lipolysis, LDL is formed which can be taken up by the liver or extrahepatic
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tissues via LDLR for cholesterol turnover or excretion. In case of elevated LDL-C,
atherogenesis will develop where these small LDL can be oxidized and eventually
macrophages will recognize these particles via scavenger receptor A (SRA) and/or cluster
of differentiation 36 (CD36). Once they are taken up by macrophages present in the
intima, an inflammatory process will start which will results in foam cell formation. With
this ongoing process plaque will buildup, leading to a fatty streak and a fibrous cap
formation which can eventually rupture. The rupture results in a thrombus which can
cause acute myocardial infarction, a major symptom of cardiovascular disease, or even
sudden death19.

Homeostasis occurs in every system of the human body. Therefore, in regards to
lipoprotein metabolism, HDL plays a role in removing cholesterol from the extrahepatic
tissues via RCT20. The major apolipoprotein associated with HDL is apo AI which is
primarily synthesized in the intestines and liver. When apo AI associates with
phospholipids, it has a discoidal shape. Apo AI is a structural protein that mediates
transfer of cholesterol from extrahepatic tissues, such as macrophages, via ATP-binding
cassette transporter 1 (ABCA1), as well as activates lecithin:cholesterol acyl transferase
(LCAT)18. HDL becomes mature as more sterol cholesterol is loaded into the particle core
and trapped by LCAT-mediated formation of cholesteryl ester, where the shape of HDL
changes form discoidal to spherical18. This mature particle, or small HDL, is recognized
by ATP-binding cassette subfamily G member 1 (ABCG1) due to the interaction of the
receptor and apo AI17. While in circulation, cholesteryl esters in HDL can be transferred
to apo B containing lipoproteins, such as VLDL and LDL, via cholesteryl ester transfer
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protein (CETP)18. Then HDL goes to the liver where it is recognized by scavenger
receptor class B type 1 (SR-B1), taken up and targeted for elimination through the bile.

2.1.3. Dietary Fat and Cholesterol
Diet plays an important role in health-related diseases, especially for cardiovascular
disease (CVD) where a poor diet is a factor associated with the disease. For many years,
the ideal nutritional lifestyle was maintaining calorie intake and energy expenditure
equilibrium and decrease dietary fat intake21. As a results, diets low in fat and high in
carbohydrates had been recommended in 1980, and in parallel, there was a rise in obesity
rates in the United States21. Therefore, current changes in dietary recommendations for
the types of fats to be consumed are based on scientific evidence, considering results in
nutritional science research, to promote a healthy dietary pattern as seen on the Dietary
Guidelines for Americans 2015-2020 (DGA)9.

In regards to CVD the consumption of dietary fats and cholesterol has been questioned,
and it is well established that intake of saturated fatty acids (SFA) are associated with
CVD risk to a certain extent22. Without a doubt, trans fat has many adverse effects
towards CVD risk such as raising LDL-C, lowering HDL-C and increasing inflammation,
for these reasons its consumption should be limited21. Additionally, epidemiological data
have shown that SFA intake results in an increase of LDL-C23, which is a well-known
factor for CVD risk. In the United States the average intake of SFA is 10.7% of total
energy24, and emerging research has been focusing on the replacement of SFA with other
fats in order to reduce the risk for CVD. This is in accordance to the most recent DGA

9

which recommends limiting calories from saturated fats by consuming less than 10% of
calories per day9. The idea of SFA being replaced by other macronutrients is not very well
established, but there are different recommendations from authority agencies in regard
to substituting SFA with polyunsaturated fatty acids (PUFA), monounsaturated fatty acids
(MUFA), protein and carbohydrates. Nevertheless, studies have shown that substituting
SFA with total carbohydrates increases the risk for coronary heart disease 25,26, since
refined starch and added sugar are precursors for de novo lipogenesis leading to increase
in plasma triglycerides, another major risk factor for CVD.

The fate of SFA is determined by the length of the fatty acid chain. There are three
different chains: short chain fatty acids with 1-6 saturated carbons, medium chain fatty
acids (MCFA) with 7-12 saturated carbons, and long chain fatty acids (LCFA) with 13 or
more carbons that can contain one or more double bonds22. Interestingly, the substitution
of LCFA to MCFA can affect the absorption and metabolism of these fatty acids. MCFA
is absorbed and transported through the portal vein directly to the hepatocytes where it
can enter the mitochondria without needing the carnitine shuttle and be utilized for fatty
acid oxidation27. On the other hand, LCFA are absorbed via chylomicrons as previously
described and consequently taken up by adipose tissue. In addition, LCFA require the
carnitine shuttle system to enter the mitochondria for fatty acid oxidation27. Therefore,
replacing LCFA in the diet to MCFA can affect these metabolic pathways, in addition
research have suggested a possible increase satiety and energy expenditure with MCFA
intake, which are major factors that help promote weight management.
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Saturated fatty acids that are primarily consumed in the American diet are myristic acid
(14:0), palmitic acid (16:0), and stearic acid (18:0)22. Interestingly, stearic acid has been
shown to reduce LDL-C and have no negative affect on CVD risk23 because during its
metabolism it is converted to oleate (18:1, n-9), an monounsaturated fatty acid28. Food
sources most common in the American diet that are high in SFA are cheese (16.5% of
SFA intake) and milk (8.3% of SFA intake), which have not shown an association to CVD
risk in epidemiological studies as well as meta-analyses of 26 studies when these were
consumed22. Nevertheless, the DGA recommends reducing the intake of SFA in addition
to consuming fat-free or low-fat dairy9. Thus, these foods high in SFA have other bioactive
compounds with anti-oxidant and anti-inflammatory properties that may lower risk for CVD
and are still targeted for reduced consumption strictly due to their fat content.

Another dietary fat that is highly consumed in the American diet is monounsaturated fatty
acids, where oleic acid represent 92% of MUFA consumed 22. Sources of oleic acid
include plant-based olive oil, canola oil, nuts, butter and animal sources such as meat,
dairy and eggs29. Studies demonstrate that diets high in MUFA (>12% total calories)
resulted in lower fat mass and blood pressure when compared to diets low in MUFA
(≤12% total calories)30. Other researchers have found that consumption of high MUFA
diets (>15% total calories) were associated with increased HDL-C, decreased
triglycerides and blood pressure31, as well as body composition differences and
reductions in weight32. The mechanism thus far to how MUFA promote cardiovascular
health are primarily based on alteration of lipid and lipoprotein profile 33. MUFA shifts fat
catabolism as well as inactivates sterol regulatory binding protein 2 (SREBP2), an
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important transcription factor for endogenous cholesterol production, in addition to
increasing expression of LDL receptors in the liver by regulating acyl-CoA cholesterol
acyltransferase when subjects consumed a diet high in oleic acid 34. Therefore, food
sources high in MUFA may promote lower risk to CVD, especially foods that contain other
bioactive compounds.

Another category of fats that has been investigated is PUFA, primarily linolenic acid (n-3)
and linoleic acid (n-6). Meta-analysis and epidemiological studies show that substitution
of SFA with PUFA can reduce risk for CVD 17%35 and 25%36 respectively. Furthermore,
a systematic review investigating randomized control trials with CVD risk outcomes
observed that the replacement of 5% energy of SFA with PUFA reduced LDL-C by 10
mg/dL as well as total cholesterol to HDL-C ratio by 0.1637. Elderly participants without
CVD (> 65 years old) at the start of an observational study were followed for 18 years,
and higher plasma linoleic acid levels was associated with lower CVD mortality, also
having high concentrations of both n-3 and n-6 PUFA showed a 54% lower mortality
risk38. Few studies have investigated effects of linolenic acid consumption and CVD risk
due to the fact that small amounts are found in dietary sources which is not feasible for
SFA substitution, but growing evidence shows relationship between alpha linolenic acid
and cardiometabolic wellness22. Consequently, substituting SFA for PUFA in the diet
lowers the incidence of CVD and promotes cardiovascular health benefits.

Cholesterol is an essential lipid molecule due to its structure and functional properties.
Importantly, cholesterol is part of biological membranes whose purpose is to stabilize lipid

12

rafts and membrane proteins. It is also used in cellular communication in regards to nerve
conduction, intracellular transport and endocrine signaling39. Structurally, cholesterol
serves as a precursor for steroid hormones, vitamin D3, and cholic acid for bile acid
synthesis40. Since cholesterol has a polar hydroxyl group, it is insoluble in water, and
therefore carried in lipoproteins in the bloodstream. Maintenance of cholesterol
homeostasis involves the metabolism of lipoproteins, dietary cholesterol, and de novo
cholesterol biosynthesis which is regulated by cholesterol utilization and excretion 41.
Consequently, elevated cholesterol in serum results in health problems, primarily
cardiovascular disease13. As a result, dietary cholesterol has been targeted as a major
contributor to CVD risk.

The main dietary cholesterol food sources include egg yolk, shrimp, beef, pork, poultry,
cheese and butter9. Before the removal of dietary cholesterol recommendation of fewer
than 300 mg/day from DGA9, no scientific evidence was used to support the hypothesis
that dietary cholesterol increased plasma cholesterol and therefore increased risk for
CVD. Now the most recent DGA states no limit for dietary cholesterol intake, but
recommends eating as little as possible to promote a healthy eating pattern9. In addition,
the DGA mentions that food sources of cholesterol are also high in saturated fats, which
targets these food groups, but even though eggs are an exception there has been a
decrease in consumption among the American population42.

Notably, the hepatic cholesterol pool is made up of exogenous cholesterol coming from
the diet and endogenous cholesterol from de novo synthesis of hepatic and/or extra-
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hepatic tissue13. Thus, case-control studies have shown no relationship between dietary
cholesterol and coronary heart disease (CHD) risk in both men and women despite the
difference of 16 mg/day of dietary cholesterol on a 2500 kcal diet between groups43.
Additionally, epidemiological studies that have shown association of dietary cholesterol
to CVD risk present confounding variables of increased saturated fat and decreased
dietary fiber intake which significantly influence the interpretation of the data43.
Consequently, a concrete biological explanation for dietary cholesterol consumption and
risk for CVD is difficult since the daily cholesterol metabolism (exogenous and
endogenous) is over 1000 mg. With that, eggs have been targeted for their dietary
cholesterol content and for increasing risk for CVD since they contribute to one fourth of
dietary cholesterol consumed in the American Diet44.

2.2. Eggs
2.2.1. Eggs Benefits - Nutrients
Eggs are a high food source of dietary cholesterol, however they are also a food source
relatively low in saturated fatty acid, rich in nutrients and vitamins, and very affordable13.
With the idea that dietary cholesterol has a potential link to CVD risk, the consumption of
eggs was low in the United States42 during the years 2010-2015 of the Dietary Guidelines
for Americans (DGA). Interestingly, the most current DGA egg intake per capita increased
in America within the last few years42. These data show that the population has become
more aware of the benefits in eggs which include a great source of high-quality protein,
vitamin A, E, D and B12, folate, selenium, iron and choline45. Additionally, one large egg
has 72 kilocalories46, and is most frequently consumed for breakfast. Studies have shown
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that eliminating eggs from a daily breakfast will result in consumption of high caloric foods
and poor nutritional status47. Individuals that consume eggs have higher intake of vitamin
E, D and B12, carotenoids (lutein and zeaxanthin), folate, selenium and choline47–50 as
well as monounsaturated fatty acids51–53. Therefore, the nutrients in eggs can contribute
to the recommended dietary allowance (RDA)54 for micronutrients in accordance to the
DGA9, and may help prevent dietary deficit intake that may affect different diseases.

The DGA recommends limiting caloric intake and focusing on nutrient-dense foods as a
way of preventing the risk for chronic diseases such as obesity, cardiovascular disease,
diabetes, and cancer9. In addition, the acceptable macronutrient distribution ranges for
male and female adults are 10-35% of proteins, 45-65% of carbohydrates and 20-35% of
total fat9. For cardiovascular disease prevention, clinical guidelines recommend lowering
total dietary fat percentage consumption, in addition to reducing intake for saturated fatty
acids (<10%), trans fatty acids (<1%), while monounsaturated fats and n-3
polyunsaturated fats should account for the remainder fat calories55. In regards to dietary
cholesterol, 2015-2020 DGA has removed the limit of <300mg/day and states that egg
yolks are “higher in dietary cholesterol but not saturated fats”9. Eggs make a great
affordable food to be included in the American diet as a prospective functional food.

Balancing the amount of each macronutrient is important for a healthy diet. An egg is low
in carbohydrates, and contains an average of 12g/100g of proteins and lipids45. Since
eggs are typically consumed as a breakfast food, the low carbohydrate content45, high
satiety index56 and protein45 are key factors in reducing appetite as well as energy intake
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throughout the day52,57. Studies have shown that high protein intake when compared to
carbohydrates has an impact on plasma ghrelin, a gastrointestinal peptide that helps in
regulating appetite58. When consuming two eggs per day in comparison to oatmeal, a
heart healthy food, for breakfast, a decrease in appetite, caloric intake, and fasting plasma
ghrelin was observed due to the high protein and moderate carbohydrate intake (50%)52.
Even though the glycemic index in this intervention did not differ, glycemic load was lower
with the egg intake which lowers the consumption of carbohydrates following a breakfast
with eggs52. Also, consuming eggs for breakfast in comparison to bagels resulted in lower
glucose, insulin and ghrelin in adult men 57. The decrease in plasma ghrelin can be
attributed to the increase in satiety caused by proteins in eggs. Eggs have high-quality
proteins with the highest biological value. Proteins in eggs have been shown to delay
gastric emptying as well as lowering post-prandial ghrelin59. In addition, eggs are an
economical source of protein that can contribute to protein in the diet.

The majority of protein in eggs is mostly in the egg white 46. The high-quality protein in
eggs aid in protein synthesis and maintenance of skeletal muscle mass 8. An average of
6.3 grams of total protein are in one large egg10, which can contribute to protein functions
as well as provide essential amino acids60. The most abundant amino acids in eggs are
leucine, glutamic and aspartic acids, in addition to branched and aromatic amino acids.
Egg white contains a great amount of leucine (15 grams of egg white = 1300 mg of
leucine) which has been shown to promote a maximal anabolic response in young adults,
therefore augmenting body mass61. Some other desirable effects of leucine include
triggering skeletal muscle synthesis, stimulating muscle cells hypertrophy, reducing
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muscular protein breakdown as well as reducing associated signaling pathways by
decreasing mRNA downregulation62. Egg white proteins impact inflammation, and the
serine proteinase inhibitor present in eggs allows proteins to be absorbed intact without
being degraded or broken-down by trypsin in the digestive system63,64. Examples of these
proteins include ovalbumin, ovotransferrin, ovomucin, lysozyme and avidin which can be
highly digestible when cooked in comparison to raw protein intake 64,65. Egg lysozymes is
a promising alternative for chronic inflammatory treatment. Supplementation of
lysozymes to a pig model of colitis induced with dextran sulfate resulted in a reduction of
inflammation and colitis symptoms, while increasing anti-inflammatory markers such as
interleukin 4 and transcription growth factor beta, indicating egg lysozymes as a potential
therapeutic for this prevalent disease66. Additionally, ovotransferrin an egg yolk phosvitin,
showed antibacterial activity by reducing inflammatory cytokines in both a mouse colitis
model and E. coli respectively67,68. When ovalbumin is degraded, it forms an active
peptide called ovokinin that has an effect in reducing blood pressure in hypertensive
rats69. Also a reduction in diastolic blood pressure in healthy young adults has been
attributed to an increase in egg consumption48. Overall, proteins present in eggs play an
important role in muscle mass synthesis and inflammation reduction.

Egg are low in saturated fatty acids and one large egg contains an average of 187 mg of
dietary cholesterol10. Phospholipids in eggs are highly concentrated in the egg yolk. About
1.3 grams of phospholipids which constitute about 30% of total lipids in a whole egg are
concentrated in the egg yolk70. Glycerophospholipid phosphatidylcholine is the most
abundant phospholipid in egg yolk (71% total phospholipid), and other phospholipids
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include

phosphatidylethanolamine

(18%),

lysophosphatidylcholine

(3%),

phosphatidylinositol (4%), lysophosphatidylethanolamine (1%) and the sphingolipid
sphingomyelin (2%)71. Fatty acids can vary according to the diet, age and environment of
the hen, but the majority are long chain saturated and monounsaturated fatty acids 8.
Egg’s phospholipids have been shown to be highly bioavailable with an absorption greater
than 90%. Most of the phospholipids are incorporated into HDL lipoproteins instead of
apo B containing lipoproteins or other lipids carriers72. Consumption of 3 eggs per day in
metabolic syndrome participants results in phosphatidylethanolamine and sphingomyelin
species in HDL particles in comparison to yolk-free alternative73. Additionally, egg intake
increases HDL cholesterol in various others populations, as well as different amounts of
eggs consumed51,52,74–76. Egg intake has been shown to not only increase HDL
cholesterol, but also modulate HDL metabolism by increasing ATP-binding cassette
transport A1, promoting anti-inflammatory activity, and resulting in larger HDL particle
size with less atherogenic properties, which may increase anti-oxidant enzymes
associated with HDL51,74,76,77. Most research focuses on the pro and anti-inflammatory
outcomes related to phosphatidylcholine from eggs. In regards to anti-inflammatory
properties, treatment and supplementation have shown positive clinical results in colitis,
reduced inflammatory damage in arthritis and lowered tumor necrosis factor alfa in a
neuroinflammation mouse model78–80. On the other hand, eggs are a rich source of dietary
cholesterol, however cholesterol absorption varies among individuals81 due to cholesterol
biosynthesis regulation in response to exogenous cholesterol51,77,82. Nevertheless,
despite eggs being a high source of dietary cholesterol, the concern of egg consumption

18

has been shifting from its dietary cholesterol to its choline content and formation of
atherogenic metabolite trimethylamine-N-oxide.

In addition to proteins, phospholipids and cholesterol, eggs contain vitamins and minerals
as well as carotenoids. The carotenoids present in the egg yolk, lutein and zeaxanthin,
are known for their antioxidant properties, and their composition can also vary according
to the hen’s diet50,83. Despite the low quantity of carotenoids in eggs, in relation to plant
sources, egg carotenoids have shown to be more bioavailable especially in boiled versus
scrambled eggs84. These carotenoids are carried by lipoproteins, and egg consumption
has been shown to increase plasma lutein and zeaxanthin50,76, where lutein is accessible
to exert a protective effect against age-related macular degeneration85,86. Lutein has
antioxidant activity due to its double bonds that is able to quench reactive oxygen species
and free radicals87. This activity has been shown in vitro and animal studies, as well as
various tissues including the eye, liver and aorta

88–90

. The mechanism that has been

shown to be very protective in the eye macular oxidative damage induced by blue light 91,92
is via a singlet oxygen quenching with the free radicals resulting in unsaturation and
resonant stabilization93. With that, one large egg contains an average of 190 mcg of total
carotenoids, where lutein and zeaxanthin are more than 90% of the carotenoids 46. Egg
consumption has improved carotenoids status, increased dietary intake and plasma lutein
and zeaxanthin in healthy young adults51,76, metabolic syndrome participants50, and older
adults (>60 years of age) with altered lipid profile94.
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Eggs provide fat-soluble vitamins and B vitamins, as well as minerals that can contribute
to lowering the risk of diseases also due to their antioxidant activity95. In addition, nutrients
in eggs can aid on the risk of low-nutrient intake in vulnerable populations such as
children, pregnant women and elderly45. Minerals present in eggs include phosphorus,
selenium, iron and zinc, where one egg has the recommended daily intake (RDI) of 16%,
29%, 9% and 9%, respectively, of these minerals. In addition, eggs also contain 10% of
RDI for vitamin A, D, E, K, B2, B12, biotin and pantothenic acid. 96 Some minerals and
vitamins can be fortified in eggs by enhancing the hen’s diet. Oxidative damage and
homeostasis are regulated by the expression of antioxidant enzymes which can be
affected by inflammation, aging, smoking and toxins96. Antioxidants can also be
consumed in the diet that can potentially prevent reactive oxygen species damage and
help maintain homeostasis as well as cellular functions 96. Some of these natural
antioxidants, which are also present in eggs, include vitamin E, carotenoids and some
peptides with such properties96. Vitamin E plays an important role in reducing lipid
peroxidation reaction due to its phenolic hydrogen radical that is donated to the lipid
peroxyl radical, consequently becoming a more stable radical97. Consumption of eggs
increases dietary vitamin E intake (1.1 mg per large egg) and absorption49, resulting in
higher vitamin E in plasma which shows how eggs affect positively the bioavailability of
fat soluble vitamins98. Addressing the contribution of egg intake to increase vitamin E is
crucial since more than 90% of American do not meet the recommended amount of
vitamin E for their age, sex, and health needs99. The most active form of vitamin E, tocopherol, is known for protecting long chain polyunsaturated fatty acids in the
membrane against oxidation96. In addition, vitamin E is carried in the LDL and HDL where
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they also protect against oxidation of these lipoproteins which can contribute to lowering
risk for cardiovascular disease in both men and women 100,101. Lastly, eggs are a great
source of vitamin D (6% of daily value), especially since it is a nutrient of concern due to
low consumption in the United States which can affects its biological functions9. Intake of
eggs increase dietary vitamin D in healthy adults 48. Even though the amount of plasma
vitamin D concentration remains in debate, 30-70% of the American adults have low
plasma vitamin D which is associated with cardiovascular disease, osteoporosis, cancer,
and other diseases102,103.

The most abundant protein in egg whites, ovalbumin (54%), has antioxidant properties
due to its free thiol groups that regulate redox reactions and bind to metal ions 104.
Peptides formed from the degradation of ovalbumin by trypsin have shown antioxidant
and angiotensin I-converting enzyme inhibition properties which can be beneficial for
hypertension. In addition, it slowed down low density lipoprotein oxidation, an important
factor contributing to cardiovascular disease105. The second most abundant protein in egg
white, ovotransferrin (12%), has superoxide dismutase-like activity towards superoxide
anions, demonstrated to be higher than ascorbate or serum albumin, and it prevents ironinduced lipid peroxidation100. Selenium (17% of daily value) and iodine are also present
in eggs and contribute to its antioxidant properties. Selenium is an essential mineral for
antioxidant proteins such as glutathione peroxidase and other selenoproteins 106, while
iodine deficiency can cause excessive hydrogen peroxide due to stimulation of the thyroid
gland100. Egg intake has shown to increase selenium intake in healthy young adults,
therefore contributing to antioxidant properties of this mineral48,49 Consequently, the
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proteins, vitamins and minerals in eggs have shown to play a role in disease as well as
contribute to dietary deficiencies.

2.2.2. HDL Functionality and Inflammation
Epidemiological data suggest that HDL-C levels are inversely correlated with CVD risk
while LDL-C is a major factor contributing to atherosclerosis development107. As
mentioned before, HDL particles play a role in the acceptance of excessive cellular
cholesterol from extra hepatic tissues and its transport back to the liver108. LDL is mainly
responsible for delivering cholesterol to peripheral tissues. Nevertheless, apolipoproteins
are emerging as better predictors for heart disease risk in comparison to lipoprotein
cholesterol concentrations (HDL-C and LDL-C)109, and eggs have shown to play a major
role in changing lipoprotein particle size, HDL functionality and improving inflammation.

For that, it is important to further enhance HDL functionality and prevent oxidation of LDL
particles. HDL composition, including apo AI and antioxidant enzymes such as
paraoxonase 1 (PON1), is crucial in determining the particle’s purpose and fate107. Apo
AI is the major structural protein in HDL, helping in cholesterol transport and homeostasis.
In addition, apo AI has anti-inflammatory properties by inhibiting interleukin-1-beta and
tumor necrosis factor alpha production in rheumatoid arthritis, Crohn’s disease and other
inflammatory diseases110. HDL has anti-oxidant properties attributed to PON1 activity, as
well as endothelial protective effects by inducing endothelial nitric oxide synthase 111.
Interestingly, studies have shown that an increase in PON1 activity is associated with
lower risk for CVD112, consequently favoring changes in macrophage cholesterol
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homeostasis, and resulting in increased cholesterol efflux and decreased cholesterol
biosynthesis113. HDL is also associated with serum amyloid A (SAA), an acute phase
protein that is secreted in response to inflammation. SAA is inversely correlated with
PON1 because of their opposing properties114. Another biomarker of inflammation is
advanced

oxidation

protein

products

(AOPP),

an

oxidation

product

from

myeloperoxidases, that play a role in atherosclerosis and fatty liver diease115. For this
reason, it is important to further understand the role of egg consumption as a dietary
approach to raise HDL-C and improve HDL functionality in order to prevent CVD risk.

2.3. Choline Metabolism
2.3.1. Choline – Essential Nutrient
Over two decades, choline has been recognized as an essential nutrient11. Choline is a
water soluble nutrient that is important for various functions such as being part of the
neurotransmitter acetylcholine, cell membrane structure for phospholipids, lipid
transportation as part of lipoproteins composition, as well as serving in methyl-group
metabolism for homocysteine reduction116. Choline is necessary for phospholipid
synthesis, especially one of the major phospholipids that is phosphatidylcholine (PC)
which itself has various important functions, in addition to lysophosphatidylcholine,
choline

plasmalogen, and

sphingomyelin,

all being

important for membrane

composition11. In regards to neurobiology, choline is important for fetal brain and memory
development as well as decreasing the chances of neural tube defect117,118. In the hepatic
tissue, PC is required as the main component for the formation and secretion of very lowdensity lipoprotein119. Therefore, the liver has the ability of producing choline moiety
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from phosphatidylethanolamine N-methyltransferase pathway120. Nevertheless, choline
needs to be consumed through the diet and bioavailable in plasma because of its vast
demand for various biological functions.

Choline deficiency can result in fatty liver and muscle damage as signs of subclinical
organ dysfunction120. Dietary free choline is absorbed in the intestine via choline
transporters into the portal circulation, which is later converted to PC in liver121. Animal
and plant sources of choline are in the form of PC, and most of PC (>90%) is primarily
absorbed in the intestine71,122. Lipid soluble compounds from food choline sources (PC,
sphingomyelin glycerol phosphocholine) are broken down by phospholipase D to form
free choline, and then absorbed into the thoracic duct where it by-passes the liver123.
Choline can also be converted into betaine in an irreversible pathway mediated by choline
dehydrogenase and betaine aldehyde dehydrogenase in nucleated cells124. Betaine can
serve as methyl group donor to homocysteine and form methionine, an essential amino
acid123, and/or serve as an osmolyte for water reabsorption in kidney tubules125. Some
plant sources are rich in betaine (such as beets) which can spare choline requirements
while serving as methyl donor since betaine cannot be converted to choline 116. Thus far,
choline toxicity (3.5 g/day) was determined based on the lowest level that caused adverse
events (hypotension)126. Adequate intake (AI) for dietary choline are based on age and
gender, or pregnancy and lactating for females, established by the United States Institute
of Medicine’s Food and Nutrition Board in 1998 126. Male and Female adults (≥ 19 years
old) are recommended to consume 550 and 425 mg per day respectively126. Based
on 2009–2012 National Health and Nutrition Examination Survey (NHANES; n =16,809)
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data for dietary choline intake, the average US adult population (19-30 years old)
consumes 324 mg/day12 which is clearly below the AI for both genders. Therefore, choline
deficiency and its symptoms can result from this low intake of dietary choline which is of
concern for nutrition scientists and public health professionals.

Dietary choline can be found in great amounts in various food sources such as dairy
products, eggs, chicken liver, wheat germ/bran, bacon, pork loin, beef liver, shrimp,
soybean and other legumes/vegetables123. The major interest is the bioavailability of
either free choline or its esterified forms and their presence in plasma following a regular
intake. Emerging research has shown that egg consumption (0, 1, 2, 3 eggs per day for
four weeks each) increased dietary choline, where in the consumption of 2-3 eggs/day
participants were meeting dietary choline AI, and also an increase in plasma choline was
observed which shows high bioavailability from choline found in eggs48. In addition, when
eggs were consumed in comparison to an oatmeal breakfast, dietary and plasma choline
was higher with egg intake74. Unfortunately, choline has been shown to be a precursor
for trimethylamine-N-oxide (TMAO) formation which has been related to increase in
cardiovascular disease risk4. Fortunately, recent research shows that consuming three
eggs per day in comparison to a choline supplement, increase dietary and plasma choline
without increasing fasting plasma TMAO127. With that, eggs have been targeted for being
a high source of dietary choline, besides past demonization for its cholesterol content,
and raising risk for cardiovascular disease.
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2.3.2. TMAO and Atherosclerosis
Choline is also metabolized in the colon by the gut microbiota into a metabolite known as
trimethylamine (TMA) and other methyl amines. These metabolites are absorbed in
circulation, and presumably excreted in the urine128. Once in the blood stream, TMA can
be further oxidized when it reaches the liver by flavin monooxygenases (FMO) to form
TMAO129. In a large cohort study, elevated plasma TMAO was a predictor for
cardiovascular disease risk4 which has piqued researchers interest in TMA/TMAO
formation and its precursors.

Gut microbiota composition can influence choline metabolism. The presence of the
microbes responsible for converting choline to TMA can affect the bioavailability of dietary
choline. How the colonization of these bacteria occur remains unknown, but it is based
on factors such as host genotype and diet. Nine strains of bacteria, from the phyla
Firmicutes and Proteobacteria130, have been identified for metabolizing choline to TMA.
Formation of TMA can also be from carnitine, betaine, ergothioneine and TMAO124. Lcarnitine can be found in red meat and dairy products 131. Carnitine plays an important
role in the transport of long chain fatty acids from cytosol to mitochondria, and half of the
carnitine consumed in the diet is absorbed in the intestines while the other part is
metabolized by the gut microbiota to form TMA132. Betaine is highly concentrated in
spinach, wheat germ and wheat bran123, and it can also be formed from reduction
reactions of choline or L-carnitine leading to the formation of TMA. Another pathway is
demethylation of betaine to form dimethylglycine followed by decarboxylation to generate
TMA124. Thirdly, ergothioneine is derivative of histidine and it cannot be synthesized by
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mammals, and foods containing ergothioneine include mushrooms, meat, and some
beans133. The role of ergothioneine in humans is not known, and its degradation also
results in the formation of TMA124. Marine fishes contain high amounts of TMAO (3 mg/g),
and 50% is absorbed by the body and eventually secreted in the urine, while the
remainder is reduced to TMA by the gut microbiota 134,135. One very important factor that
contributes to TMA metabolism is diet, and individuals that consumed a Western Diet
usually produce 50 mg of TMA/day from the action of the microbiota 124. TMA is a
metabolic waste secreted in the urine136, therefore, research has been focusing on TMAO
since most of TMA that is not secreted is converted to TMAO, a more stable metabolite
in plasma.

TMAO has varying biological properties across species and tissues. In humans, TMAO
plays a role in kidney function to destabilize the effects of urea 137, it helps protein structure
stability, and favors protein folding by inhibiting endoplasmic reticulum stress 138. Plasma
levels of TMAO are influenced by diet, gut microbiota composition, kidney function, and
activity and genotype of FMOs139. Formation of TMAO happens primarily in the
hepatocytes by FMO3, which is ten times more active towards TMA than other FMOs129.
Other isoforms of FMO are present in other organs such as FMO1 in both the liver and
kidney that can also contribute to TMAO production 140. FMO3 functions in glucose and
cholesterol metabolism, where its activity is up/downregulated by sexual hormones or
diminished due to single nucleotide polymorphisms. Increased gene expression of FMO3
in both human and animal cell models has resulted in an increased lipogenesis as well
as increased glucose secretion mediated by pathways of peroxisome proliferator-
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activated receptor alpha and Kruppel-like factor 15, suggesting the role of FMO3 in
regulating lipid and glucose homeostasis141. Since FMO3 is also regulated by hormones,
higher expression levels are seen in females because testosterone in males represses
FMO3 activity and expression140. Another key regulator of FMO3 is farnesoid X receptor
(FXR), and treatment with FXR agonist and cholic acid (bile acid) resulted in increased
expression of FMO3142. Additionally, knockdown of FMO3 in animal cells has resulted in
increased ER stress and inflammation. This mechanism is due to a damping of liver X
receptor activation which has an effect on cholesterol balance, therefore showing that the
TMA/FMO3/TMAO pathway is an important pathway regarding inflammation and lipid
homeostasis129. Lastly, FMO3 is suppressed by insulin, and increased expression is seen
in obese and insulin resistant humans and animals 143. Consequently, TMAO formation
can play a major role in increasing risk for CVD and also development of metabolic
dysfunctions.

With that, high levels of TMAO in mice have been shown to increase expression of
scavenger receptors, CD-36 and SR-A1, responsible for initiating the atherosclerosis
process4. Also a decrease in ABCA1 expression in murine macrophages suggested
TMAO as a pro-atherosclerotic metabolite for foam cell formation 144. Additionally, high
concentrations of plasma TMAO, choline and betaine have been predictors for coronary
heart disease in humans, and TMAO levels are related to greater aortic lesions area in
animals4. Therefore, once more eggs are targeted for raising risk for CVD, but this time
because they are high in dietary choline.
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2.3.3. Eggs and Choline
Since eggs are high in dietary choline (130 mg per large egg)10, a contributor for TMAO
formation and elevated plasma TMAO is associated with increased risk for heart disease,
egg consumption concerns the population in regards to CVD risk. When six healthy
individuals consumed an increasing dose of egg yolk (0, 1, 2, 4, or 6 egg yolks) for
breakfast, there was an increase in plasma TMAO within 6-8 hours of egg consumption
which after 24hrs returned to base levels. Additionally, urine TMAO also increased within
the 24hrs period after the egg yolk breakfast, which indicates that 11-15% of dietary
choline is converted to TMAO, but it clears after a period of 24hrs. In this acute model
design, there was a TMAO variability within individuals due to the fact that there is a
difference in gut microbiota composition among people, as well as FMO3 activity,
especially between genders145. Another study addressing increasing doses of egg intake
(0, 1, 2, 3 eggs per day for 4 weeks each) found no changes in fasting plasma TMAO with
increasing doses, on the contrary there was an increase in plasma choline 48. Similarly,
when comparing 2 eggs per day versus an oatmeal breakfast, fasting TMAO remains
unchanged while plasma choline is higher with the egg consumption74. Since free choline
and choline esters are absorbed differently146,147, a free choline source such as choline
bitartrate supplement resulted in an increase in fasting plasma TMAO in healthy
individuals in addition to an enhancement in platelet aggregation6. In that case, the
optimal egg intake of 3 eggs per day previous determined by DiMarco et al.48 that
increased plasma choline and not raised risk for CVD was a rationale for an intervention
comparing choline bitartrate supplementation. In order to address the gap in the literature,
in comparison to choline bitartrate supplementation, eggs increased fasting plasma
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choline without increasing plasma TMAO, and no difference in LDL-C/HDL-C ratio was
seen while the cholesterol biosynthesis pathway was downregulated49,51. For this, it is
safe to say that eggs can be included to the diet of healthy individuals.
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Chapter 3: Effects of 3 Eggs per Day on Dietary Intake,
Anthropometrics, Glucose and Plasma Lipids When
Comparing to Choline Bitartrate Supplementation
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3.1. Background
Eggs are one of the main source of dietary cholesterol for Americans47. Even though the
latest Dietary Guidelines for Americans has removed the dietary cholesterol limit
recommendation of < 300 mg/day9, people are still concerned about eating eggs. Eggs
are not only a rich source of dietary cholesterol but other nutrients such as
polyunsaturated fat, folate, vitamins A and E47. Additionally, carotenoids in eggs have
shown to elevate concentrations in plasma when consuming eggs at an increasing
dosage(0, 1, 2, or 3 eggs per day)76, or along with a carbohydrate-restricted diet50. These
carotenoids, lutein and zeaxanthin, are important antioxidants protecting against agerelated macular degeneration45. Eggs are also a rich source of high quality protein, which
can help promote satiety throughout the day in comparison to a heart healthy breakfast
such as oatmeal52. Nevertheless, eggs are a great source of dietary choline, an essential
nutrient in the American diet11. Choline has many biological functions that can help
promote organ function and overall health.

Another concern regarding egg consumption is due to its possible negative effects on
plasma lipids, body mass index, and liver enzymes. However, studies have shown
favorable plasma changes caused by egg intake without increasing biomarkers for
cardiovascular disease (CVD). When metabolic syndrome individuals were consuming 3
eggs per day as part of a carbohydrate-restricted diet, fasting plasma triglycerides
decreased for a period of 12 weeks along with favorable changes in parameters of
metabolic syndrome75. On the other hand, healthy individuals consuming increasing
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dosage of eggs per day48 or 2 eggs versus oatmeal for breakfast52 showed no changes
in fasting plasma triglycerides, glucose, nor liver enzymes.

Research is still being done to show that there is no relationship between dietary
cholesterol intake and plasma cholesterol7, so it is important to evaluate and further
support this hypothesis. Previous studies show that egg intake, increased total
cholesterol52 and LDL-C48, while increasing HDL-C, and observed no changes in LDLC/HDL-C ratio. This ratio is established as a well-predictor of CVD risk, where a ratio >
2.5 indicates that an individual has greater chance of developing CVD 148.

We were interested in evaluating the effects of dietary choline from eggs in comparison
to choline from a supplement in order to test the outcome on CVD risk biomarkers. For
that purpose, we used these two choline sources to primarily focus on choline metabolism
and trimethylamine-N-oxide (TMAO) formation since it has been previously shown that
elevated plasma TMAO is a predictor of CVD4. Therefore, we hypothesized that intake of
3 eggs per day would result in high dietary nutrients present in eggs, increase in HDL-C
and no change in LDL-C/HDL-C in comparison to same amount of choline in a dietary
supplement (choline bitartrate) in young healthy population.

3.2. Materials and Methods
3.2.1. Participant Recruitment and Screening
To evaluate our hypothesis, we recruited 30 healthy men and women considering the
inclusion criteria 18-30 years old, body mass index (BMI) of 18.5 to 29.9 kg/m2, blood
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pressure (BP) ≤ 140/90 mm Hg (average of three readings), healthy biochemical plasma
parameters (fasting glucose ≤ 126 mg/dL, total cholesterol (TC) ≤ 240 mg/dL, triglycerides
(TG) ≤ 150 mg/dL, creatinine (CREA) (0.5-0.9 mg/dL for females or 0.7-1.2 mg/dL for
males) who were willing to consume either 3 eggs per day or 1 ½ tablets for four weeks
each. The exclusion criteria were current or past liver disease, renal disease, diabetes,
history of stroke, cancer, any severe infectious diseases and/or heart diseases; taking
glucose or TG lowering medications or supplements; allergy to eggs or components of
choline bitartrate supplement, vegan or vegetarian; taking choline supplements; pregnant
or lactating; and taken antibiotics in the previous month. The protocols used for this
intervention were previously approved by the University of Connecticut Institutional
Review Board (protocol #H16-194), and participants gave consent prior to screening
process. This clinical trial is registered at clinicaltrials.gov, trial #NTC03142763.

The screening process included explanation of consent form and answering questions
about study design and intervention. Anthropometrics data was assessed during
screening such as blood pressure measurements (3 readings when the participants were
sitting down with one minute in between each reading), height, weight, and waist
circumference (3 measurements using a flexible tape above the iliac bone directly on the
skin). Afterwards, participants were asked for a 12-hour fasting blood sample for posterior
analysis of plasma glucose and lipids using an automated spectrophotometer (Cobas
c111, Roche Diagnosis, Indianapolis, IN, USA). Participants were also instructed on how
to complete dietary records during the intervention. In addition, they were asked to
consume 3 eggs for breakfast or take choline supplement (1 ½ tablet) that were given
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during the respective interventional arm with their first meal, preferably in the morning to
keep consistency among participants. Researchers also asked subjects to maintain a
normal exercise routine throughout the intervention (monitored by exercise records) and
avoid or abstain from consuming foods high in dietary choline and its derivatives (e.g.
betaine) as presented on Table 1. Researchers purchased eggs (grade A, large white)
from a regional supermarket (Big Y, CT, USA), while supplements were purchased from
Best Naturals, where each tablet provided 265 mg of choline. In order to match the
amount of dietary choline in eggs (~ 390 mg), participants had to consume 1 ½ tablets (~
397.5 mg). In regard to eggs preparation, no instructions were given to the participants;
however, they were allowed to consume only the eggs provided by the researchers.

TABLE 1
Foods containing choline and betaine to be avoided or consistently consumed during
study based on participants common food choices (adapted from Zeisel et al., 2003123)
Foods

Total Choline (mg/100g food)

Total Betaine (mg/100g food)

Bacon

124.89

3.14

Pork Loin

102.76

1.39

Pretzel

38.40

236.45

Shrimp

70.60

218.74

Spinach, cooked

24.78

645.06

Spinach, raw

22.08

599.81

Wheat Bread

26.53

201.41

Total choline is the sum of choline, phosphocholine, glycerophosphocholine, phosphatidylcholine, and
sphingomyelin

Based on standard deviation from previous studies where changes in plasma choline
were observed following consumption of 3 eggs per day for four weeks48, this study is
powered to detect a 7% and 25% difference in HDL-C and plasma choline48 respectively,
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at 80% power, with significance two-sided at level of  = 0.05. Therefore, we estimated
that 25 participants would be sufficient to observe differences between intervention
groups. Thirty participants were enrolled to allow for attrition and because there is a
known intra individual variability of plasma TMAO in humans, 5 additional participants
were enrolled.

3.2.2. Experimental Design
This was a 13-week crossover dietary intervention (Figure 1), where enrolled participants
started with a two-week washout period. During washout periods, participants were not
allowed to consume any eggs or egg-based food (e.g. quiche) for the remainder of 9
weeks except during the eggs arm of the intervention. They were asked to fill out 3-day
dietary and exercise records (2-week days non-consecutive and 1 weekend day).
Subjects were then randomized by a computer software (A: eggs, B: choline) where a
letter was assigned to each participant to determine who would start with the egg
intervention versus the choline bitartrate supplementation.

For visit 1, researchers collected diet and exercise records, assessed anthropometrics,
and 40mL of fasting blood into ethylenediaminetetraacetic acid (EDTA)-coated vacutainer
tubes. Participants were then given enough eggs for a week along with a compliance
sheets to be filled out (self-reported compliance). They were required to come to the
research center every week to pick-up more eggs and return that week’s compliance
sheet. In case of less than 80% of compliance, participants were removed from the study.
On the other hand, subjects that started on the choline bitartrate supplement were given
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enough tablets for 30 days and instructed to take 1 ½ tablet (already split in half by
researcher) every day for 4 weeks.

At the end of the first arm, visit 2, records and anthropometrics data were collected, and
80 mL of fasting blood sample was drawn from the participant. Participants then went
through another washout period of 3 weeks and the same instructions for the first washout
period were given, and then they returned for visit 3 (similar to visit 1) for data collection.
Subjects were then assigned to alternate treatments, finishing the study with visit 4 and
data collection corresponding to visit 2 assessments.

Screening

Visit 1

Visit 2

Visit 3

Visit 4

Eggs
Washout

Week: 0

1

Eggs
Washout

Choline
Bitartrate
2

3

4

5

6

7

8

Choline
Bitartrate
9

10

11

End

12 13

FIGURE 1
Crossover 13-week study time line for dietary intervention

3.2.3. Dietary Records
Once enrolled, researchers instructed participants how to fill out dietary records. They
were asked to complete 3-day dietary and exercise records during each arm of the
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intervention. Subjects were asked to choose two non-consecutive week days and one
weekend day during the week prior to their visit (visit 2 or visit 4). Diet records were used
to evaluate the consistency of their diet throughout the intervention to assure researchers
that no dietary patterns were changed besides the consumption of eggs or choline. Since
these treatments where not isocaloric, participants were allowed to substitute the eggs
for breakfast to whatever they chose without researcher’s recommendations. This was a
dietary lifestyle intervention; therefore, no eating advice was given. The main purpose
was to evaluate the difference in having either of these dietary choline sources and the
relationship between dietary choline intake and cardiovascular disease risk.

During each visit, the diet records were carefully evaluated to assure the consistency and
accuracy of the entered data in front of the participants in case any questions needed to
be answered about entered values. Using Nutrition Data Systems for Research Software
(2016), developed by the Nutrition Coordinating Center at the University of Minnesota
(Minneapolis, MN, USA), diet records were analyzed. This software allows researchers
to obtain daily average of macro and micronutrients, food groups, and other nutrients of
interest. In addition, an analysis of the meal was performed to obtain the average of
nutrients consumed for breakfast instead of the entire day since participants were
instructed to consume dietary choline during breakfast.

3.2.4. Anthropometrics and Plasma Biochemical Parameters
During all visits, anthropometrics data and fasting blood samples were collected for
posterior analyses. For weight measurement, an electronic scale was used to the nearest
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0.1 kg. Participants were asked to wear light clothes, empty pockets and remove shoes
during each visit to ensure consistent measurements throughout study without conflicting
factors. Subjects were then asked to step on a standing stadiometer to measure height
to the nearest 0.5 cm. With both of these parameters body mass index (BMI) was
calculated (kg/m2). In order to assess central adiposity, waist circumference was
measured by placing a flexible measuring tape directly on the skin of the participants,
above the iliac crest to the nearest 0.5 cm, and an average of three measurements was
recorded. Blood pressure was also monitored throughout the intervention for these
participants. They were asked to sit quietly with feet flat on the ground for about 5 minutes
before measuring the blood pressure using a portable automatic blood pressure cuff
(Omron HEM 7320-Z), in which an average of 3 readings were recorded with a minute
between each reading.

For blood samples, subjects were asked to fast for 12 hours prior to each visit and drink
only water before coming to the department for a blood draw. Using common phlebotomy
procedures, blood was drawn from the median cubital vein into an EDTA-coated or serum
separator (SS) with silica clot activator vacutainer tubes. During visit 1 or 3 about 30 mL
of plasma and 10 mL of serum were collected, while visit 2 or 4 about 70 mL of plasma
and 10 mL of serum were obtained from each participant. The EDTA tubes were inverted
a couple of times and put on ice for posterior centrifugation. The SS tubes were allowed
to clot for 30 minutes at room temperature prior to centrifugation. Tubes were balanced
and centrifuged at 2000 x g for 20 minutes. Plasma and serum were aliquoted into 1.5
mL cryovial tubes and stored at -80ºC for posterior analysis.
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After centrifugation, 500 L of plasma were aliquoted into a cuvette, and using an
automated spectrophotometer (Cobas C111, Roche Diagnostics, Indianapolis, IN, USA),
plasma glucose (mg/dL), triglycerides (mg/dL), total cholesterol (mg/dL), high-density
lipoprotein cholesterol (HDL-C) (mg/dL), alanine aminotransferase (ALT) (mg/dL) and
aspartate aminotransferase (AST) (mg/dL), C-reactive protein (CRP) (mg/dL) and
creatinine (mg/dL) were measured. To calculate low-density lipoprotein cholesterol (LDLC) the Friedewald equation was used149. LDL-C/HDL-C ratio was also calculated as a
biomarker for cardiovascular disease risk. Creatinine values were used in the Modification
of Diet in Renal Disease formula150 to calculate estimated glomerular filtration rate as a
biomarker of renal function for these participants.

3.2.5. Statistical Analysis
Variables were analyzed using Student t Test comparing the end of egg intake versus
choline bitartrate supplementation, as well as between baseline and end of each
treatment. Positive outcomes were used to assess for correlation using Pearson’s
correlation. Grubbs’ test was used to compute for outliers due to variability between
participants. All statistical analyses were done using SPSS for Mac, version 25 (IBM
Corporation). Level of significance was set at p < 0.05.

3.3. Results
3.3.1. Baseline Characteristics
Thirty-five individuals were assessed for eligibility and thirty satisfied the inclusion criteria.
Participants were enrolled on January 2017 (n=30) for this dietary intervention and
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randomly distributed to eggs (n=15) or choline bitartrate supplement (n=15) for 4 weeks.
Due to personal reasons, one participant dropped out during the first phase of the study
while in the eggs arm (Figure 2). After 3 weeks, they were crossed over to the alternate
treatment. Endpoint data was collected from twenty-nine participants and analyzed for all
variables49.
Discontinued (n = 1)
• Unable to comply
with egg quantity

Egg intake
(n = 15)
Assessed for
eligibility
(n = 35)

Enrolled and
randomized
(n = 30)

Cross-over

Analyzed
(n = 29)

Choline Bitartrate
supplementation
(n = 15)

Excluded (n = 5)
• Did not meet
inclusion criteria

FIGURE 2
Flowchart of the 13-week crossover study when comparing egg versus choline bitartrate
intake in young, healthy individuals

Baseline anthropometrics (BMI and waist circumference), blood pressure, plasma fasting
lipids, glucose, estimated glomerular filtration rate (eGFR) are shown on Table 2, as well
as gender and age. In addition, baseline differences between sex were evaluated, shown
on Table 2. Participants were homogeneously distributed based on gender, age and BMI.
On the other hand, waist circumference (p=0.009) and eGFR (p=0.001) were lower, while
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systolic blood pressure (p=0.001) and fasting plasma glucose (p=0.003) were higher in
females when compared to males.

TABLE 2
Baseline characteristics of young, healthy men and women (n=30) participating in a 13week crossover intervention with egg versus choline bitartrate supplement intake for 4
weeks each49,51
Parameters

Total

Female

Male

p-value

Gender (%)

-

52%

48%

0.910

Age (years)

25.6  2.3

25.8 ± 1.9

25.2 ± 2.8

0.679

BMI (kg/m2)

24.3  2.9

23.2 ± 2.5

24.4 ± 6.0

0.498

Waist circumference (cm)

86.9  7.1

83.5 ± 4.7

89.8 ± 7.3

0.009

Systolic blood pressure (mmHg)

108.9  10.9

103.1 ± 9.34

116.0 ± 8.9

0.001

Diastolic blood pressure

70.2  7.2

68.7 ± 6.17

70.3 ± 7.5

0.387

Glucose (mg/dL)

92.7  5.0

90.8 ± 4.6

95.5 ± 3.6

0.003

Triglycerides (mg/dL)

66.1  33.3

64.3 ± 27.1

70.3 ± 41.0

0.640

Total cholesterol (mg/dL)

163.7  29.3

166.6 ± 30.66

159.9 ± 29.6

0.561

HDL-C (mg/dL)

69.9  10.0

70.81 ± 11.9

68.46 ± 7.7

0.545

LDL-C (mg/dL)

80.6  25.2

82.89 ± 26.5

77.40 ± 25.3

0.576

LDL-C/HDL-C ratio

1.2  0.4

1.20 ± 0.4

1.16 ± 0.4

0.814

eGFR (mL/min)

98.0  14.1

94.98 ± 14.6

99.39 ± 10.9

0.001

(mmHg)

Values are presented as mean  SD

3.3.2. Dietary Records Analyses
Based on self-reported compliance, which was assessed weekly during both
interventions, an overall of 98% compliance was observed among participants. When
comparing egg intake versus choline bitartrate supplement no difference in total energy
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intake and protein was observed. On the contrary, total percent fat intake (p=0.001),
dietary cholesterol (p=0.001), selenium (p=0.001), vitamin E (p=0.026) saturated fat
(p=0.001), monounsaturated fat (p=0.001), lutein and zeaxanthin (p=0.018) were higher
in the eggs group. While total percent of carbohydrate (p=0.001), dietary fiber (p=0.001),
folate (p=0.020), and glycemic load (p=0.001) were lower during the eggs intervention.

TABLE 3
Dietary record of healthy, young population (n=29) at the end of each intervention arm,
egg versus choline supplement intake for 4 weeks each49,51
Nutrient

Eggs

Choline

p-value

Energy (kcal/day)

1771.38  376.30

1841.66  423.19

0.386

Protein (%)

23.05  6.90

20.39  9.01

0.110

Fat (%)

40.14  7.57

32.14  8.81

0.001

Carbohydrate (%)

34.53  8.81

45.02  11.30

0.001

Total Fiber (g/day)

15.40  7.05

20.16  6.54

0.001

Glycemic Load

79.93  29.08

110.52  42.99

0.001

Cholesterol (mg/day)

746.93  100.69

198.72  68.32

0.001

Selenium (mcg/day)

138.49  33.71

110.52  28.01

0.001

Choline (mg/day)

696.65  96.95

690.91  96.99

0.745

Vitamin D (µg/day)

6.24  2.44

5.71  5.28

0.548

Vitamin E (IU)

13.38  6.63

11.17  5.37

0.026

Betaine (mg/day)

107.34 72.19

135.99  75.65

0.087

Folate (mcg/day)

322.41  95.74

390.52  160.79

0.020

Saturated Fat (%)

13.44  4.46

10.91  3.58

0.001

Monounsaturated Fat (g)

29.44  8.84

22.42  7.68

0.001

Polyunsaturated Fat (g)

16.09  6.48

15.72  5.97

0.809

Lutein + Zeaxanthin(μg)

1474.34  724.72

1115.41  746.15

0.018

Values are presented as mean  SD
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Since participants were advised to consume both eggs and choline bitartrate supplement
for breakfast, macronutrients differences were evaluated. Higher total fat (p=0.001) and
lower carbohydrate (p=0.001) intake was observed, while total protein (p=0.056) intake
trended to be higher in the eggs group for breakfast.

NS

Macronutrients Percentage

100%

*

90%

*
Fat

80%
70%
60%

Carbs

50%
40%
30%

Prot

20%
10%

0%

Eggs

Choline

FIGURE 3
Dietary macronutrient intake during breakfast. Percentages of fat (black bar),
carbohydrates (Carbs; gray bar), and protein (Prot; white bar) after consuming three eggs
per day versus choline bitartrate supplement for 4 weeks each. Values are presented as
means  standard deviation for 29 young, healthy men and women. Bar with superscripts
differ at p < 0.05 as determined by paired Student’s t test analysis. *p < 0.05 between
interventions; NS = not significant considering p < 0.0549

Analyses of daily food group consumption during the interventions were also evaluated
with dietary records. There were no significant differences between beef, poultry, fish,
pork, dairy, total vegetables, nuts and seeds when comparing egg intake versus choline
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supplementation. The only differences observed was in legumes (p=0.014) intake, which
was lower in the eggs group when compared to choline bitartrate intake (Table 4).

TABLE 4
Portion of daily consumption of number of servings in beef, poultry, fish, dairy, total
vegetables, legumes, and nuts and seeds, during the eggs and the choline bitartrate
dietary supplement periods in healthy, young participants (n =29) 49
Food Group

Eggs

Choline

p-value

Beef

0.95  1.14

0.96  1.35

0.972

Poultry

2.96  2.79

3.04  2.80

0.875

Fish

0.39  1.36

0.66  1.26

0.227

Pork

0.63  1.83

0.47  1.70

0.346

Dairy

1.52  0.87

1.87  1.22

0.148

Total Vegetables

2.40  1.52

2.80  1.34

0.217

Legumes

0.09  0.24

0.28  0.36

0.014

Nuts and Seeds

0.96  1.57

0.83  1.20

0.587

Values are presented as mean  SD

3.3.3. Anthropometrics and Plasma Biochemical Parameters
When comparing egg consumption as opposed to choline bitartrate supplementation, no
changes were observed among anthropometrics measurements (BMI and blood pressure
– systolic and diastolic), fasting plasma glucose, creatinine, eGFR, and triglycerides. As
expected, total cholesterol was higher (p=0.040) during egg consumption, as well as HDLC (p=0.030) and LDL-C (p=0.049), and no changes observed in LDL-C/HDL-C ratio
(p=0.775). As a measurement of low-grade inflammation, plasma C-reactive protein
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(CRP) was used, and egg consumption showed lower CRP (p=0.046) in comparison to
choline bitartrate intake.

TABLE 5
Anthropometrics measures and fasting plasma biochemical parameters for participants
(n=29) at the end of each intervention arm, three egg versus choline bitartrate supplement
intake for 4 weeks each51
Parameters

Eggs

Choline

p-value

BMI (kg/m2)

24.1 ± 2.8

24.0 ± 2.60

0.347

Systolic Blood Pressure (mm Hg)

108.1 ± 10.7

108.9 ± 10.9

0.604

Diastolic Blood Pressure (mm Hg)

68.8 ± 7.7

68.8 ± 6.3

0.939

Glucose (mg/dL)

92.3 ± 6.0

90.9 ± 5.7

0.226

Creatinine (mg/dL)

0.85 ± 0.11

0.86 ± 0.13

0.415

eGFR (mL/min)

100.6 ± 12.3

99.5 ± 12.9

0.553

Triglycerides (mg/dL)

69.6 ± 29.5

73.6 ± 36.0

0.355

Total Cholesterol (mg/dL)

172.6 ± 35.8

162.7 ± 30.7

0.040

HDL-C (mg/dL)

61.0 ± 16.0

57.0 ± 14.3

0.030

LDL-C (mg/dL)

97.7 ± 31.7

90.9 ± 26.3

0.049

LDL-C/HDL-C

1.72 ± 0.72

1.70 ± 0.67

0.775

C-reactive Protein (mg/dL)

0.18 ± 0.37

0.32 ± 0.59

0.046

Values are presented as mean  SD. Student’s t test was used to determine statistical significance

Liver enzymes were also measured as important biomarkers for hepatic inflammation
(Figure 4). Interestingly, there were no differences between interventions, egg intake
versus choline bitartrate supplementation for aspartate amino transferase (AST)
(p=0.214) and alanine amino transferase (ALT) (p=0.653). As expected, no differences
were found between baselines for AST (p=0.123) and ALT (p=0.275) followed by the
washout periods. On the other hand, choline bitartrate supplementation increased AST
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(p=0.028) and showed a trend in increasing ALT (p=0.072) (Figure 4) in these young,
healthy individuals.
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FIGURE 4
Plasma aspartate amino transferase (AST) and alanine amino transferase (ALT) for
baseline and end of each dietary intervention for 13-week crossover study assessing the
effects of consuming three eggs versus choline bitartrate supplementation per day for 4
weeks each. Values are presented as means  standard deviation for 29 young, healthy
men and women. Bar with superscripts differ at p < 0.05 as determined by paired
Student’s t test analysis. *p < 0.05 between interventions

We also evaluated Pearson’s correlation between dietary cholesterol intake and total
plasma cholesterol during the egg intervention. Since one large white egg contains an
average of 187 mg of dietary cholesterol (based on NDSR data), consuming three eggs
per day exacerbated the recommendation. As expected, there was no correlation
(p=0.701) between dietary cholesterol (mg/day) and plasma total cholesterol (mg/dL)
when participants were consuming 3 eggs per day for four weeks.
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FIGURE 5
Pearson’s correlation graph between dietary cholesterol (mg/day) and plasma total
cholesterol (mg/dL) for participants (n=29) consuming three eggs per day for 4 weeks

3.4. Discussion
3.4.1. Baseline Characteristics
With the removal of dietary cholesterol recommendation of 300 mg per day from the most
recent Dietary Guidelines for Americans (DGA)9, the consumption of eggs remain a
concern publicly in the United States. It is not known if this change in the DGA has caused
an increase in egg consumption of about 9% from 2015 to 2017151. Additionally, data
supports that egg consumption does not increase biomarkers of cardiovascular disease
(CVD) risk in clinical trials conducted in various populations48,53,75. The spotlight has been
brought on eggs regarding its dietary choline content and its relationship with
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atherosclerotic metabolite trimethylamine-N-oxide (TMAO)4. Therefore, this study had the
purpose to further investigate in a dietary lifestyle intervention two sources of dietary
choline on risk factor for CVD and cholesterol metabolism in a young, healthy population.

The best study design for a dietary intervention is a crossover randomized controlled
trial152, where participants are their own control since each individual is different in
regards to metabolism, the main interest of this study. Therefore, looking at baseline
characteristics, these participants as a total fall within the young adult age range, with a
healthy mean BMI, normal blood pressure, as well as fasting glucose and plasma lipids.
When considering healthy individuals, this means that they don’t meet the criterion for
metabolic syndrome, obesity, diabetic, or hyperlipidemia. Additionally, these participants
had a functional kidney which was evaluated by plasma creatinine in order to calculate
the estimated glomerular filtration rate (eGFR). On the other hand, as expected, there
were significant differences in baseline characteristics in waist circumference and eGFR
when comparing genders. Surprisingly and randomly, females had higher systolic blood
pressure and fasting plasma glucose then males at baseline, but they were still within the
parameters for healthy adults.

3.4.2. Dietary Records Analyses
Compliance was assessed based on self-reported questionnaires. Participants were
given a weekly sheet to complete for the daily intake of eggs and choline bitartrate
supplement during its respective interventional period. Since this was a dietary
intervention, the dietary records collected during each treatment were used for analysis.
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Participants were asked to complete a two non-consecutive week day and one weekend
day in order to guarantee consistency and average of daily nutrient consumption. As a
lifestyle dietary intervention, no advice was given on what foods to eat. Participants
voluntarily adapted to the treatments, and no difference in total caloric intake was
observed between eggs and choline bitartrate consumption. This is interesting, because
it shows that the total energy intake didn’t change between interventions, even though
each large egg contains 70 kcal46 while choline bitartrate supplement has no energy
source. In this case, participants were adapting their diets voluntarily to accommodate
their energy needs during the supplement phase.

Interestingly, no change in total protein intake was observed between each intervention.
It was expected that during the egg consumption participants total protein intake would
be higher since eggs are a source of high quality protein8. For this reason, consumption
of food groups was evaluated, and no difference was observed. Consequently, individuals
were consuming protein from other sources that were not beef and poultry since
consumptions rates of these protein sources also remained unchanged among
treatments. Since participants were advised to consume the eggs for breakfast and take
the choline bitartrate supplement with their first meal, macronutrients intake for the
morning (breakfast) period was evaluated. The protein intake was still not significantly
different, but it trended to be higher during breakfast possibly due to the egg-protein.
Therefore, throughout the day participants were choosing plant-based proteins such as
legumes, since that was the only food group significantly different in the daily dietary
values.
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As expected, fat and cholesterol intake were higher with the egg intake. This is due to fat
(5 grams per egg) and cholesterol (180 mg cholesterol per egg) content in eggs 10. Dietary
cholesterol has been thought to be associated with increase in plasma total cholesterol,
but previous studies with egg intake48,51–53,75 have not seen such association which will
be further discussed in the following section. Different types of fat play a major role in
disease risk23, and understanding the influence of dietary fats in CVD is essential. Diet is
an important modifiable factor that can impact CVD risk and atherosclerosis
progression153. Mediterranean style diets have many beneficial effects because of the
high consumption of fruits, vegetables, and other foods that have low glycemic index 154.
In this aspect, in addition to being low in glycemic index, eggs are also a satiating food
which can contribute to low caloric intake 155. For this study, differences in saturated,
monounsaturated and polyunsaturated fat were further evaluated.

First, eggs contain 1.6 grams saturated fat (SFA) per large egg8, and it is of concern due
to evidence showing that diets high in SFA can increase LDL-C, shown to be a primary
factor for CVD22. Additionally, the DGA recommends intake of SFA to be less than 10%
of calories per day9. The eggs intervention had a higher intake of SFA in comparison to
the choline bitartrate supplementation, which is primarily due to the amount of SFA in
three eggs (4.8 g per day)10. Participants during the egg intervention were consuming
about 35% carbohydrates daily in comparison to the choline supplement where they
consumed 45%. According to the DGA, the recommended range for carbohydrate intake
is 45-65% of total calories9. Recent observational studies have shown no association
between dietary SFA and CVD risk156,157. Further research has demonstrated that
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increased consumption of SFA in the context of a low carbohydrate diet does not
significantly increase plasma SFA158. For this reason, higher SFA intake during the eggs
phase was not of concern.

Second, according to the DGA, the majority of fat calories should be consumed from
monounsaturated fat (MUFA)45. MUFA is also synthesized by the liver after carbohydrate
intake21. The majority of MUFA in Western diets is oleic acid, which is also one of the fatty
acids in the phospholipids present in eggs71. A higher intake of dietary MUFA was
observed

during

the

eggs

consumption in

comparison

to

choline

bitartrate

supplementation, and no change in polyunsaturated fat (PUFA) was seen. Usually, no
specific optimal intake for MUFA has been established, but it is based on the
recommended intake of SFA minus PUFA21. Some studies have suggested that replacing
5% of energy intake from SFA with MUFA resulted in a 15% lower risk for CVD36. With
that, eggs are a great source of healthy fats that can improve diet quality and replace less
nutritious foods when consumed with a balanced diet.

The total consumption of the third macronutrient, carbohydrate, was lower during the egg
intake period. This result was similar to what DiMarco et al.48 observed, which is not
surprising since participants were consuming more total fat and protein, egg’s main
macronutrients, during the eggs intervention. This reduction in carbohydrate intake can
be explained by the consumption of eggs instead of carbohydrates, especially breakfast
foods rich in fiber such as breads and cereals. Additionally, less legumes were consumed
during the eggs intervention, which contain more fiber159. On the other hand, a low
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glycemic load was observed with the consumption of eggs when compared to the choline
bitartrate supplement, which might be related to the low glycemic index of eggs52. Low
glycemic load foods are recommended for a healthy diet, particularly for individuals with
diabetes160. With that, eggs are low in carbohydrates and glycemic load that can be
incorporate into a healthy diet.

Fiber and micronutrients play an important role in health, in regard to inflammation and
biological function. During the egg consumption, fiber intake was lower which can
compromise gut microbiota composition. Dietary fiber is a carbohydrate polymer that is
neither digested nor absorbed, and it is fermented by the gut microbiota to produce mainly
short chain fatty acids (SCFA)161. The importance of fiber consumption is linked to the
influence of SCFA in gastrointestinal epithelial cell integrity, glucose homeostasis, lipid
metabolism, appetite regulation, and immune function162. An average American
consumes 12-18 grams/day of dietary fiber, while the DGA recommends 12 grams per
1000 kcal9. In this study, according to the DGA, participants were supposed to consume
about 22 grams per day of dietary fiber. Therefore, the lower fiber intake during the eggs
period can be explained by the consumption of eggs for breakfast instead of food rich in
fiber, such as oatmeal, cereals, breads, and granolas, those which were commonly
preferred during choline bitartrate supplementation when looking at the diet records.

Micronutrients present in eggs such as vitamin E, found in yolk, and selenium, found in
egg whites were higher with egg intake163. Consumption of dietary vitamin E, a natural
antioxidant, is not met by United States adults99, which can compromise one of its
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important function in reducing lipid peroxidation 98. Additionally, selenium, also plays a role
in the activity of antioxidant enzymes such as glutathione peroxidase 106. Another nutrient,
folate, is also present in the egg yolk (~24 µg)8, but dietary consumption of folate was
higher in the choline bitartrate supplementation. Therefore, researchers hypothesized
that since participants had a higher intake of fiber-rich foods during the supplement
intervention, such as cereal and breads which are highly fortified with folic acid164, that
may explain the higher dietary folate intake. Egg yolk also contains major carotenoids
lutein and zeaxanthin50. One of most important functions of these carotenoids include the
protective effect against age-related macular degeneration that has been prevalently
increasing worldwide165. As expected, with egg consumption, these dietary carotenoids
were higher in comparison to choline bitartrate supplement intake. Additionally, lutein has
shown to have antioxidant activity to lower CVD associated factors such as proinflammatory cytokines, aortic and plasma LDL oxidation 88. Previous studies have
demonstrated that egg consumption increases plasma carotenoids significantly50,52,76.
Thus, proving the bioavailability of antioxidant carotenoids in eggs. Despite the low intake
of dietary fiber, eggs have many beneficial nutrients that impact biological functions and
promote a healthy diet.

3.4.3. Anthropometrics and Plasma Biochemical Parameters
Further investigating the effects of dietary interventions in anthropometrics and
biochemical parameters is important, as blood was the only biological material collected
in this study. Since these were healthy individuals, as expected, no changes in
anthropometrics and fasting plasma glucose were observed when comparing treatments.
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In order to assure normal kidney function, creatinine levels were measured in plasma and
eGFR was calculated. Observing no difference in renal function was ideal since the
metabolites of interest for Chapter 5 are cleared by the kidney166. Additionally, no changes
in fasting plasma triglycerides was seen between treatments as these participants are
healthy, and eggs have not previously shown to impact triacylglycerol levels 48,52.

On the contrary, intake of three eggs had higher impact on plasma lipids in comparison
to choline bitartrate supplement. Total cholesterol, HDL-C and LDL-C concentrations in
plasma were higher with the egg intake compared to choline bitartrate supplementation.
In contrast, no change was observed in the LDL-C/HDL-C ratio, which has been shown
to be a biomarker of CVD risk148. Importantly, the increase in HDL-C is most likely due to
the cholesterol and phospholipids present in egg yolk that are incorporated into HDL
particle. An increase in HDL-C has been previously shown to coincide with increased HDL
lipid and antioxidant composition52,73,76. In previous studies, chronic consumption of 1-3
eggs per day showed an increase in plasma HDL-C without elevating other known CVD
risk factors in young, healthy populations48,52,76. Measurements of low-grade inflammation
and hepatic enzymes were assessed to see the effects of both treatments in healthy,
young adults. CRP was higher with the choline bitartrate supplementation. Additionally,
previously studies have shown the effects of eggs in reducing inflammation53. Since these
participants are healthy, what could have possibly caused the increase in inflammation
was the free choline intake and increase in atherogenic metabolite TMAO peak which will
further be discussed. Lastly, there was no significant difference in liver enzymes AST and
ALT when comparing treatments, but an increase in AST and a trend in increasing ALT
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was observed with choline bitartrate supplement intake. Liver enzymes in plasma are
markers of hepatic dysfunction and injury167. Since the oxidation of trimethylamine to
trimethylamine-N-oxide is mediated mainly by hepatic flavin monooxygenase 3 (FMO3)
and FMO3’s role in cholesterol metabolsim140, it is possible that as a results exacerbating
liver function cause the slight elevation in hepatic plasma enzymes. At last, Pearson’s
correlation showed that dietary cholesterol has no association with total plasma
cholesterol levels. Consequently, eggs can be added to a healthy dietary pattern without
having negative effects on anthropometrics and plasma biochemical parameters.

3.5. Strengths and Limitations
The main strength of this study was the study design with a cross-over study. This way
each subject serves as their own control. Additionally, a cross-over design has many
strengths, including demonstrating reversibility, compensating for unsuccessful
randomization, and improving study efficiency by not using time to recruit subjects 152.
Other strengths include the collection of dietary records and the compliance subjects
showed which improved retention in the study. Carrying out this intervention in healthy
individuals is also a strength, since it is not yet known the difference between two dietary
choline sources in healthy individuals. It was ideal to understand the possible effects in
this population before extrapolating to a population at higher risk of CVD. Finally, a great
strength of this study was the consistency in dietary habits, which helped the researchers
attribute the findings to the intervention treatments and no other confounding dietary
pattern habits.
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As all studies have limitations, one limitation of this study could be the lower intake of
dietary fiber, which can affect the gut microbiota and have effects in other metabolic
features159. Since the main goal here was to investigate a metabolite formed by the gut
microbes, TMA, using dietary choline as a substrate, any dietary influence on the
composition of the gut bacteria needed to be taken in consideration.

Another limitation was the inability of assessing more nutrients in the software as well as
intake of carnitine, TMA, and TMAO as these could also play a role on the results. On the
contrary, food groups were assessed in a way of measuring thus compounds as they are
present in red meat and seafood. Lastly, one more limitation was the difference in calories
and macronutrients between treatments during the breakfast period. Even though this
was a lifestyle intervention, it would have been interesting to match both treatments
caloric during breakfast as this was the meal researchers advised participants to consume
the eggs and choline bitartrate supplement.

3.6. Conclusions
Overall, this 13-week dietary intervention had the objective to evaluate the effects of
consuming two different dietary choline sources on biomarkers for CVD risk. Even with
the removal of upper limit for dietary cholesterol from the 2015-2020 DGA, egg
consumption is still controversial to the majority of the population. Following intake of
eggs, participants had higher plasma HDL-C and did not increase the LDL-C/HDL-C ratio,
a known biomarker for heart disease risk, compared to choline bitartrate supplement.
Additionally, dietary positive changes such as vitamin E, selenium and anti-oxidant
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carotenoids, as well as healthy fats with lower carbohydrate intake were seen with the
egg consumption. With that, dietary cholesterol via egg intake has no relationship with
plasma cholesterol and impacts positively the diet of healthy young adults.
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Chapter 4: Impact of 3 Eggs per Day Intake Compared to
Choline Bitartrate Supplement on Apolipoproteins, HDL
Functionality, and Cholesterol Metabolism
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4.1. Background
Data suggest that levels of HDL-C are inversely correlated with CVD risk107. HDL particles
play a role in accepting excessive cellular cholesterol from extra hepatic tissues and
delivering it to the liver in a process called reverse cholesterol transport (RCT)108. On the
other hand, levels of LDL-C have been clearly established as a major risk factor for
CVD108, as LDL is mainly responsible for distributing cholesterol to peripheral tissues.
Nevertheless, apolipoproteins are emerging as better predictors for heart disease stability
in comparison to lipoprotein cholesterol concentrations (HDL-C and LDL-C)109.

The importance of HDL in RCT is to prevent the accumulation of lipids in extra hepatic
tissues. Briefly, discoidal lipid-poor HDL associated with apolipoprotein (apo) AI will bind
to ATP-binding cassette subfamily A member 1 transporter (ABCA1), while lipid loaded
HDL will bind to ATP-binding cassette subfamily G member 1 transporter (ABCG1) for
cholesterol uptake from macrophages located in the intima and/or from extra hepatic
tissues168. Furthermore, HDL can be atheroprotective due to its composition, size and
functional properties107. In contrast, LDL under normal physiological conditions will
transport cholesterol to various cells and tissues, and LDL receptor (LDLR) is the major
cell surface receptor responsible for regulating cholesterol uptake and transport 169. When
LDL is oxidized, it can be taken up by macrophages via scavenger receptors and form
foam cells, which is the initial stage of atherosclerosis 15. Thus, it is important to further
explore HDL functionality and the modification that can occur in LDL particles.
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HDL particles carry not only apo AI, but antioxidant enzymes, such as paraoxonase 1
(PON1)107. Besides apo AI being the major structural protein in HDL particle, it is also
involved in cholesterol transport and homeostasis. In addition, apo A1 has antiinflammatory properties due to inhibition of interleukin-1-beta (IL-1) and tumor necrosis
factor alpha (TNF-) production in human diseases such as rheumatoid arthritis, Cohn’s
disease and other immunoinflammatory diseases110. On the other hand, HDL has antioxidant properties due to PON1 and endothelial protective effects by inducing endothelial
nitric oxide synthase111. Studies have shown the increase in PON1 activity is associated
with lower risk for CVD112, along with favorable changes in macrophage cholesterol
homeostasis, consequently leading to an increase in cholesterol efflux and decrease
biosynthesis113. Lastly, serum amyloid A (SAA) associated to HDL is an acute phase
protein that is secreted in response to inflammation, and inversely correlated with PON1
due to their opposing characteristics114. On the other hand, advanced oxidation protein
products (AOPP) are mediated by oxidation from myeloperoxidase that play a role in
atherosclerosis and inhibition of RCT mediated by HDL via SR-B1170. Therefore, there is
an interest in understanding the role of egg intake as a dietary approach to raise HDL-C
and HDL functionality to prevent risk for CVD.

The hypothesis was that with egg intake HDL functionality would be higher while hepatic
cholesterol biosynthesis would be lower in comparison to choline bitartrate
supplementation. Higher functionality would be observed from higher concentration of
apoAI and PON1 activity (arylesterase and lactonase), lower concentrations of AOPP. In
regard to HDL metabolism, higher expression of the genes ABCA1 and ABCG1 were
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expected with the egg intake. Secondly, egg intake would lower cholesterol biosynthesis
pathway by lowering expression of HMGCR, LDLR, SREBP2 target genes.

4.2. Materials and Methods
4.2.1. Apolipoproteins Quantification
Previously collected plasma was used to quantify apolipoprotein simultaneously using a
Luminex MAGPIX Analyzer (EMD Millipore). For the purposes of this study, a Luminex
xMAP multiplex assay kit (Invitrogen) was used to measure apolipoprotein (apo) AI, apo
B, and apo E. The principle of this analysis is based on adding the sample to a mixture of
color-coded beads, pre-coated with each analyte-specific capture antibodies of interest
based on the purchased kit. In that case, the antibodies will bind to each analyte, and
then a biotinylated detection antibody is added specific to each analyte forming an
antibody-antigen sandwich. Then, phycoerythrin (PE) conjugated streptavidin is added,
which will bind to the biotinylated detection antibodies. With the Luminex Magpix
Analyzer, a magnet in the analyzer holds the magnetic beads in a monolayer, while two
spectrally distinct light-emitting diodes (LED) illuminate the beads. One LED identifies the
analyte that is being detected, and the second LED determines the magnitude of the PEderived signal. Each well is imaged with a CCD camera, and a concentration is obtained
based on signal and standard curve of each analyte.
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4.2.2. PON1 Activity Measurement
Serum that was obtained from the participants at the endpoints of each intervention was
used to measure paraoxonase 1 (PON1) activity. This enzyme has arylesterase activity
towards phenyl acetate113. An in-house assay was developed to measure activity of
PON1 arylesterase in half-volume 96-well plates in 270nm absorbance in a
spectrophotometer instrument (Biotech Epoch) containing Gen5 software every 20
seconds for 3 minutes at room temperature. Calculation was done to obtain the change
in absorbance per minute and converted to units of enzyme activity (U) per mL using
theoretical unique factor.

4.2.3. Formation of AOPP Assay
Advanced oxidation protein products (AOPP) were measured in serum at different end
points of each intervention. The serum of each samples was mixed with polyethylene
glycol (PEG) reagent (Fisher Scientific) and centrifuged at 10,000 x g for 10 min at 4oC
to precipitate apo-B lipoproteins. Supernatant depleted of apo-B lipoproteins was
collected, containing HDL, and added to potassium iodide plus glacial acid solution in a
96-well plate, and incubated for 10 min at room temperature. Following, the plate was
centrifuged at 4000 RPM for 10 min at 4oC, and supernatant was transferred to a half
volume UV-visible 96-well plate to read absorbance at 340 nm in a spectrophotometer
instrument (Biotech Epoch) containing Gen5 software. Concentrations of AOPP (µmol/L)
was measured against chloramine T standard curve.
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4.2.4. Isolation of Peripheral Blood Mononuclear Cells (PBMC)
From the blood collected at the end of each intervention, 40 mL was used for isolation of
fresh PBMC on the same day of blood collection. First, whole blood was diluted with sterile
phosphate buffered saline (PBS), and then layered over Ficoll Paque PREMIUM (GE
Healthcare, Uppsala, Sweden) to form a density gradient upon centrifugation (400 x g for
35 minutes without a brake at 20ºC). Plasma, buffy coat, Ficoll gradient and red blood
cells are separated. The buffy coat, containing PBMCS, were collected and washed twice
with PBS by centrifugation at 400 x g for 15 minutes at 20ºC. Following, the pellet obtained
from the last centrifugation step was resuspended in heat-inactivated fetal bovine serum
(FBS). Fresh PBMC was used for RNA extraction, while the remaining cells were diluted
1:1 in a cryopreservation media (20% dimethyl sulfoxide in FBS) 77. Lastly, cells were
frozen in a CoolCell container (BioCision, LLC, Larkspur, CA) for 24 hours at -80°C, and
then transferred to liquid nitrogen (-196°C) for long term storage.

4.2.5. Gene Expression
Using freshly isolated PBMCs, RNA was extracted with IBI Isolate reagents (IBI Scientific,
Peosta, IA, USA) following manufacturer´s instructions. After obtaining 1 µg of RNA for
each sample, DNase I (ThermoScientific) was used for treatment followed by reverse
transcription using an iScript transcriptase kit (Bio-Rad, Hercules, CA, USA). Expression
of target genes for HDL metabolism, cholesterol efflux and metabolism and apoAI
regulation will be assessed using mRNA expression in PBMCs by quantitative real-time
polymerase chain reaction (qRT-PCR). This analysis was done using SYBR Green with
Bio-Rad CFX96 system (Bio-Rad, Hercules, CA, USA). Primer sequences will be
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acquired based on the GenBank database shown in Table 6. Expression of mRNA values
will be calculated using the threshold cycle (Ct) value. Relative expression levels of each
target gene will be determined using the comparative 2 -∆∆Ct method following
normalization to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA
expression171.

TABLE 6
Quantitative real-time polymerase chain reaction primer sequences
Target
ABCA1
ABCG1
HMGCR
LDLR
SREBP2
CD36
GAPDH
FMO3

Forward primer

Reverse primer

5′-TTTCTCAGACAACACTTGACCAAGTA-3′
5′-CGGAGGGCAGCTGTGAAC-3′
5’-CCCAGTTGTGCGTCTTCCA-3’
5’-ACTGGGTTGACTCCAAACTTCAC-3’
5’-GGGGATCCCGATGGACGACAGCGGCGGCT-3’
5’-GGCTGTGACCGGAACTGTG-3’
5’-TGTGGGCATCAATGGATTTGG-3
5´-TGTGGGCATCAATGGATTTGG-3´

5′-GGTTTTTGTGTAATGAGAGGTCTTTTAA-3′
5′-GGGTCCTTCAGGAACCGAAT-3′
5’-TTCGAGCCAGGCTTTCACTT-3’
5’-GGTTGCCCCCGTTGACA-3’
5’-GGAATTCTCAGTCTGGCTCATCTTTGACCTT-3’
5’-AGGTCTCCAACTGGCATTAGAA-3’
5’-ACACCATGTATTCCGGGTCAAT-3
5´-CTGGTTCTTTATAGTCCCTGCTG-3´

4.3. Results
4.3.1. Apolipoproteins Quantification
Apolipoproteins were measured in fasting plasma simultaneously. In comparison to
choline bitartrate supplementation, apolipoprotein (apo) AI (p=0.002) and apo E (p=0.022)
concentrations were higher with the egg intake (Figure 6). No differences were observed
with apo B (Figure 6), nor apoB/apoAI ratio (0.11  0.05/0.11  0.04) when comparing
the two treatments.
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FIGURE 6
Plasma concentrations of fasting apolipoproteins AI, B, and E with intake of three eggs
versus choline bitartrate supplement for 4 weeks each. Values are presented as mean 
SD for n=29 men and women. Bar with superscripts differ at p < 0.05 as determined by
paired Student’s t test. *p < 0.05 between interventions51

4.3.2. HDL Functionality
For measurements for HDL functionality, paraoxonase 1 (PON1) arylesterase and
formation of advanced oxidation protein products (AOPP). There were no significant
differences (p=0.366) in PON1 arylesterase activity in these healthy individuals when
comparing both interventions. In addition, AOPP was also not significantly different
(p=0.665) (Table 7).
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TABLE 7
High Density Lipoprotein functionality measurements for healthy young adults (n=29)
when comparing intake of 3 eggs versus choline bitartrate supplement for 4 weeks each
Measurements

Eggs

Choline

p-value

PON1 Arylesterase (U/mL)

97.22 ± 20.09

93.25 ± 17.86

0.366

AOPP (µmol/L)

123.38 ± 25.15

125.46 ± 20.49

0.665

Values are presented as mean  SD. Student’s t test was used to determine statistical significance

Even though no significant differences were observed with egg intake and PON1 activity,
a correlation analysis was done. A positive correlation was observed with apoAI
concentration (mg/L) and PON1 arylesterase activity (U/mL) (p=0.025) (Figure 7a) when
participants were consuming eggs while no correlation (p=0.322) was observed in the
treatment with choline bitartrate supplement (Figure 7b). On the other hand, a negative
correlation was observed between HDL-C and CRP in this study (p=0.001).

b

a

FIGURE 7
Pearson’s correlation graphs between apolipoprotein AI (mg/L) and paraoxonase 1
arylesterase activity (U/mL) for participants (n=29) consuming three eggs per day (a) or
choline bitartrate supplement (b) for four weeks each
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4.3.3. Gene Expression - Cholesterol Metabolism
Finally, the changes in gene expression for cellular cholesterol biosynthesis, uptake, and
efflux were investigated. When comparing eggs versus choline bitartrate supplement
consumption, a lower expression of the rate-limiting enzyme HMGCR (p=0.038) and a
key transcription factor responsible for regulating cholesterol synthesis, SREBP2
(p=0.008), was observed. No changes were seen in efflux transporter ABCA1 (p=0.404)
and ABCG1 (p=0.421), while a trend was detected in lowering LDLR expression
(p=0.058) with egg intake (Figure 8).
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FIGURE 8
Gene expression of 3-hydroxyl-3-methyl-glutaryl-coenzyme A reductase (HMGCR), lowdensity lipoprotein receptor (LDLR), sterol regulatory element-binding protein 2
(SREBP2), ATP-binding cassette subfamily A member 1 transporter (ABCA1), and ATPbinding cassette subfamily G member 1 transporter (ABCG1) with intake of three eggs
versus choline bitartrate supplement for 4 weeks each. Data were standardized to the
expression of GAPDH as a reference gene using the 2 (−∆∆CT) method. Values are
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presented as mean ± SD for n=27 men and women. Bar with superscripts differ at p <
0.05 as determined by paired Student’s t test after excluding outliers using Grubb’s test51

4.4. Discussion
4.4.1. Apolipoproteins Quantification
Apolipoproteins are structural proteins present in lipoproteins, which contribute to the
metabolic fate of the particle as well as its content in regards to lipid, cholesterol and
triglycerides18. Apo AI is the major apolipoprotein associated with HDL. During this
intervention, apo AI was elevated after the egg consumption. A major function of apo AI
is to facilitate RCT through the interaction with cholesterol transport receptors on cellular
membrane and accept cholesterol (from cells to lipoprotein particle)172. On the other hand,
apo B (apo B100) is the major structural protein found in VLDL and LDL particles3. In this
intervention, no difference was seen for plasma apo B, even though there was an increase
in LDL-C with egg intake in comparison to choline bitartrate supplementation. This could
be explained by an increase in the cholesterol content of LDL particles rather than the
particle number, as there is only one apo B per LDL particle 18. An possible indication of
greater abundance of HDL particles or larger HDL can be drawn from the increase in both
HDL-C and apo AI with egg intake, since it has been observed with previous intervention
studies regarding egg consumption that measured particles concentration and size 50,76.
Lastly, besides measuring LDL-C/HDL-C as a biomarker for CVD, recent clinical trials are
also reporting apoB/apoAI, and for this intervention no difference was observed with
apolipoprotein ratio18. Another apolipoprotein that is present in the particles is apo E,
present on VLDL and HDL. Apo E is important for decreasing plasma cholesterol and
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clearing triglyceride-rich lipoproteins via the LDLR and LDL-receptor related protein
(LRP)173. In this context, increase in apo E with egg intake may complement its effects on
HDL to promote RCT to the liver for bile acid synthesis and sterol metabolism 18.
Consequently, the positive changes in apolipoprotein profile with egg intake, may explain
the affect egg consumption has on increasing concentration of structural apolipoproteins
that can improve HDL particle’s functionality.

4.4.2. HDL Functionality
Besides measuring serum HDL-C, the importance of HDL functionality plays a major role
in lipid metabolism and disease risk174. Consequently, assessing HDL functionality
enhances HDL-C findings since HDL particles exhibits anti-inflammatory, antithrombotic,
and antioxidant effects, in addition to improving endothelial function. All of these
properties contribute to prevention of developing atherosclerosis. Since this was a cohort
study in healthy individuals, not much differences were expected in regard to HDL
functionality as these individuals did not have altered HDL function from baseline. Even
though no difference was observed in two markers of HDL function, PON1 activity and
AOPP concentration, positive correlations were seen with treatments. Egg consumption
shows a positive correlation between apo AI and PON1 activity, which was not seen with
choline bitartrate supplementation. These proteins have shown to interact, and it has
been previously shown that apo AI increases the activity of PON1175, an antioxidant
enzyme. Additionally, dietary cholesterol has shown to increase PON1 activity in a cohort
study evaluating food frequency questionnaires and PON1 activity in older adults, at risk
for CVD176. Three eggs per day has shown to increase PON1 activity with increasing
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doses of eggs (0 to 3 eggs per day for four weeks each) in healthy young adults76, while
two eggs per day in comparison to an oatmeal breakfast did not increase PON1 activity74.
It could be possible that the first study an additive effect was observed since there was
no washout period between each egg dose. Another measurement of HDL functionality
used here was AOPP concentration, as AOPP is a pro-inflammatory molecule released
that is negative correlated with HDL-C115,177. For this intervention, no significant
differences were observed in AOPP level, which again is due to the fact that these are
healthy individuals. Many factors can play a role in AOPP concentrations such as age,
gender, pregnancy, obesity, cardiovascular disorders, and fatty liver disease 115. On the
other hand, a negative correlation was observed between HDL-C and CRP levels, which
shows the anti-inflammatory property HDL carries when there is a functional HDL 174.
Consequently, egg intake in comparison to choline bitartrate supplement has shown to
improve HDL functionality to a certain degree in healthy young adults.

4.4.3. Gene Expression - Cholesterol Metabolism
As this was an intervention that exacerbated the recommended dietary cholesterol,
investigating the effects on cholesterol metabolism genes of interest was essential. It is
known that cholesterol metabolism is regulated at the cellular level and, particularly in the
liver, and it can impact concentrations of plasma cholesterol7. A major rate limiting step
of cholesterol biosynthesis is through the enzyme HMGCR, while the cholesterol taken
up by the cells is regulated by LDLR interactions with circulating lipoproteins.
Consumption of 3 eggs per day showed lower expression of HMGCR and a trend in
lowering LDLR in comparison to choline bitartrate supplementation. This indicates that
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with the intake of dietary cholesterol, a downregulation of HMGCR and LDLR take place
to balance the amount of circulating cholesterol. On the other hand, SREBP genes are
responsible for regulating over 30 genes involved in lipid homeostasis 178. Specifically,
SREBP2 is activated in response to low intracellular cholesterol levels with the function
to promote cholesterol biosynthesis and cholesterol uptake in order to maintain cellular
cholesterol homeostasis. With egg consumption, lower expression of SREBP2 was
observed in comparison to choline bitartrate supplementation. Since increased levels of
intracellular cholesterol will downregulate SREBP2 and affect the expression of HMGCR
and LDLR179, this explains the lower expression of SREBP2 in response to the dietary
cholesterol. As a downstream gene, SREBP2 consequently downregulated HMGCR and
it would possible to observe a downregulation of LDLR if the study had been conducted
for a longer period of time. Another possibility here, is that another transcription factor
such as LXR could be regulating the expression of LDLR in this situation with higher
intracellular cholesterol179, which would require further investigation. Surprisingly, no
differences were observed in the ABCA1 and ABCG1 gene expressions which are to lipid
transporters associated with HDL77. Since the major role of these transporters are
cholesterol efflux from macrophages to HDL particles, further investigation would be
needed as PBMCs were used in this study. Overall, with egg intake, cholesterol
metabolism is regulated without affecting plasma levels of cholesterol, and especially no
changes in LDL-C/HDL-C ratio.
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4.5. Strengths and Limitations
One great strength of this chapter was evaluating the effects of both interventions in
healthy individuals before they become a population at higher risk for CVD, by having
metabolic syndrome, being obese, or developing diabetes. Additionally, many biomarkers
were assessed for basic HDL functionality; however not major changes were observed
since these are healthy participants. Evaluating the effects of dietary cholesterol on gene
expression changes in cholesterol metabolism was also a great strength to prove that
there is no relationship between dietary cholesterol intake and plasma cholesterol. It has
been shown in this study that the body is able to regulate the exogenous and endogenous
cholesterol to maintain a healthy cholesterol plasma level.

Some limitations of this intervention were the fact that measurements of lipoprotein
particle size, diameter, and phospholipid profile of each particle was not possible to
assess. Additionally, it would have been interesting to investigate changes in cholesterol
efflux capacity of the HDL particles between interventions. Since TMAO has shown to
affect cholesterol metabolism due to the role of FMO3 in the cholesterol homeostasis
pathway129, further exploring would be interesting. Lastly, measuring other markers of
HDL functionality such as endothelial functional proteins such as ICAM and VCAM would
have completed the overall effects of egg consumption on increasing HDL functionality.

4.6. Conclusions
Despite the concern about egg intake regarding its dietary cholesterol content and risk
for CVD, these data show that egg intake increases positive biomarkers that could lower
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the risk for heart disease while others remain unchanged. Low HDL-C is an indicator of
CVD risk, therefore raising HDL-C and HDL particle functionality has become a great
interest to prevent heart disease complications. Overall, egg consumption suggests that
HDL functionality is increased, which could potentially lower the risk for CVD in healthy
young participants. The data from this intervention supports the inclusion of three eggs
per day in a healthy dietary life pattern.
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Chapter 5: Effects of 3 Eggs per Day Consumption Versus
Choline Bitartrate on Plasma Choline and
Formation of TMAO
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5.1. Background
Choline is an essential nutrient in that it participates in various biological functions11.
Some of its functions include neurotransmitter synthesis, cell-membrane signaling, lipid
transport in the lipoproteins, and methyl-group metabolism in regards to homocysteine
reduction11. With that, choline deficiency can result in metabolic disorders, such as fatty
liver due to the lack of phosphatidylcholine required for formation of very-low density
lipoprotein particles12. In fact, the average American does not meet the adequate intake
of dietary choline, especially young adults (age 19-30)12. For this reason, egg
consumption is of great interest due to its high content in choline, where most of the 1.3
g of phospholipids in a large egg are phosphatidylcholine 71. Additionally, about 90% of
phospholipids are absorbed in the small intestines before reaching the gut microbiota,
which can contribute to the elevated concentrations of choline in plasma71.

In contrast to the previous observations, emerging research is targeting choline since it
is a precursor of TMAO4. Dietary choline has been shown to be metabolized by the gut
microbiota into TMA, which is further oxidized in the liver by FMO3 to form TMAO129. High
concentrations of TMAO has an association with atherosclerosis progression by inducing
the expression of scavenger receptors (CD36 and SR-A1)5, further contributing to CVD.
There are other precursors of TMA such as L-carnitine and betaine, derived from meat
sources and some vegetables respectively124. With that, elevated concentrations of
plasma TMAO have shown global effects in decreasing RCT, increasing atherosclerosis
as well as major cardiac events5.
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For this reason, exploring the effects of egg consumption in comparison to another
choline source will help elucidate the impact on TMAO formation and CVD risk. A small
study in healthy individuals found an increase in postprandial plasma TMAO with an
increasing dose of egg yolk for breakfast, which then resulted in increased concentration
of urine TMAO145. While two studies reported no changes in fasting plasma TMAO with
egg intake in a young healthy population at an increasing dosage of eggs48 or in
comparison to oatmeal for breakfast74. It is important to note that there is a variation
between individuals due to different microbial community145 as well as polymorphism in
FMO3 gene180. Since eggs are a great source of this essential nutrient and has shown
many other health benefits, there is the need to further understand its effect in formation
of TMAO in comparison to another dietary choline source.

The hypothesis is that egg intake would result in higher plasma choline and no change in
plasma TMAO in comparison to baseline. While in comparison to choline bitartrate
supplement, egg intake would result in higher plasma choline. Additionally, choline
bitartrate supplementation was expected to increase plasma TMAO. On the other hand,
a higher expression of scavenger receptors and FMO3 was expected with choline
bitartrate supplementation in comparison to egg intake due to association of these genes
with high TMAO.
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5.2. Materials and Methods
5.2.1. Plasma Choline and Metabolites Quantification
Plasma free choline and its metabolites (methionine, betaine, dimethylglycine, and
TMAO) were measured in duplicate for baseline and endpoint of each intervention by
liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). This
method previously established by Holm et al.181 was used with some modifications based
on instrumentation182. Plasma was separated and aliquoted as previously mentioned, 50
µL of each sample were mixed with 100 µL of acetonitrile (ACN) solution containing 0.1%
formic acid and internal standards (13C3-TMAO; d13-choline). Afterwards, samples were
vortexed vigorously for about 30 seconds each, in order to coagulate proteins. In
sequence, samples were centrifuged for 5 min at 10,600 x g and 4oC, and then 10 µL of
supernatant was transferred to a vial containing 120 µL of ACN and injected into the LCMS/MS system for analysis. The system contained an LCQ Advantage Mass
Spectrometry system with electrospray ionization (ESI), a Surveyor High Pressure Liquid
Chromatography system with Alltech Prevail Silica analytic column (2.1 x 150 mm, 5 µm)
with a guard column, and a Surveyor refrigerated auto-sampler (Thermo Finnigan, San
Jose, CA). The ESI system was operated in a positive ion mode. For this analysis, mobile
phase was 19% ammonium formate (15 mmol) with 0.1% formic acid (v/v) and 81% ACN.
Flow rate was set at 500 µL/min and column temperature at 25ºC. Standard curves for
the internal standards were used for analysis. The intraassay CV was < 3.7% for each
metabolite considering duplicate measures. In house controls were used in duplicate
measurements and the CV was < 5.5% for each control and metabolite.
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5.2.2. Gene expression
As previously described, gene expression was assessed in PBMCs using target genes
specific for TMAO metabolism (FMO3) as well as CD36 associated with atherosclerosis
in regard to cholesterol uptake using primers on Table 2.

5.3. Results
5.3.1. Plasma Choline and Metabolites Quantification
Since dietary choline was matched between intervention (p=0.745), plasma choline was
analyzed to assess bioavailability in plasma following consumption from two difference
dietary sources. In comparison to choline bitartrate supplementation, egg intake resulted
in higher plasma choline (p=0.021) and increase from baseline (p=0.023) (Figure 9a).
Unfortunately, there was no change in plasma TMAO in between interventions or from
baseline (Figure 9b). Another metabolite from choline, betaine, was quantified and no
change was observed (Figure 9c). Lastly, methionine which is part of the homocysteine
pathway183 increased with egg consumption (p=0.005) (Figure 9d), while no change was
observed with choline bitartrate intake (p=0.725) or between treatments (p=0.094).
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FIGURE 9
Plasma choline (a), trimethylamine-N-oxide (TMAO) (b), betaine (c), and methionine (d)
concentrations before and after consuming three eggs per day or choline bitartrate
supplement for 4 weeks each. Values are presented as means  standard deviation for
27 young, healthy men and women. Bars with superscripts differ at p < 0.05 as
determined by paired Student’s t test analysis after excluding outliers using Grubbs’ test.
*significance at baseline versus end point; **significance eggs versus choline supplement
end point; NS = not significant49
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Intraindividual variability to egg and choline intake was observed, where some subjects
had no impact on plasma TMAO while others increased or decreased TMAO levels in
response to the treatments (Figure 10).
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3.00
2.00
1.00
0.00

Eggs

Choline

FIGURE 10
Intraindividual variability of plasma trimethylamine-N-oxide (TMAO) in response to egg
and choline bitartrate intake for young, healthy adults

5.3.2. Gene expression – TMAO metabolism
When looking into gene expression for one of the main receptors, CD36 (p=0.858),
involved in atherosclerosis progression and the key enzyme, FMO3 (p=0.392),
responsible for forming TMAO no changes were observed within treatments in healthy
adults (Figure 10). The other receptor, SRA, was not detectable in this population.

81

Relative Quantification to GAPDH

3
2.5
2
Eggs

1.5

Choline
1
0.5

0

CD36

FMO3

FIGURE 11
Gene expression for cluster of differentiation 36 (CD36) and flavin monooxygenase 3
(FMO3) using quantitative real-time polymerase chain reaction with relative quantification
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) after consuming 3 eggs per day
versus choline bitartrate supplement for 4 weeks each. Values are presented as means
 standard deviation for 29 young, healthy men and women. Student’s t test was used for
analysis after excluding outliers using Grubbs’ test49

5.4. Discussion
5.4.1. Plasma Choline and Metabolites Quantification
This study has demonstrated that intake of ~400 mg of dietary choline, whether in the
form of eggs or a choline supplement resulted in similar concentrations of plasma TMAO
in a young, healthy population. However, egg intake showed an increase in plasma
choline by 20% compared to the choline bitartrate supplement, confirming the hypothesis
of possible increase in choline bioavailability when consumed as a component of whole
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eggs. In contrast to what hypothesized, plasma TMAO were not different between egg
intake and choline bitartrate supplement. However, this finding differs markedly from
previous work which reported an increase in plasma fasting TMAO on healthy individuals
(46 ± 5 years old) with intake ~450mg of choline per day for 8 weeks 6.

As choline is an essential nutrient that needs to be consumed through the diet, even
though humans can synthesize it in small quantities11,184, the increase in plasma choline
with egg intake is very important. Choline is involved in various biological functions12, and
recent data from NHANES showed that 93% of adults (age ≥ 19 years) have inadequate
intake of daily dietary choline12. Therefore, including choline rich foods in the diet is of
great interest to prevent choline deficiency. As eggs are a good source of choline185, it is
believed that the phosphatidylcholine form of choline in the eggs is absorbed in the ileum
along with other lipids186, and that could explain the increase in plasma choline. These
participants were not meeting the required intake of dietary choline before the intervention
since their baseline dietary choline intake was 293.41  97.0 mg/day (data not shown),
and the adequate intake (AI) for dietary choline is 550 mg/day for males and 425 mg/day
females12. With the intervention they were consuming an additional ~400 mg/day of
dietary choline that was coming from either the eggs or the supplement, and therefore
reaching the daily AI.

A possible explanation for the differences in plasma TMAO with the other study
mentioned above could be the due to the role of the methyl donor pathway in this study183.
Individuals consuming eggs had higher plasma choline, betaine, dimethylglycine (DMG)
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and methionine while no changes in plasma TMAO (Figure 12). On the other hand, when
individuals were consuming choline bitartrate supplement no change in plasma choline
was observed, while a higher plasma betaine and DMG was seen, and no change in
methionine and plasma TMAO. Considering the methyl donor pathway, and the fact that
these participants were deficient in dietary choline according to the study in 2016 12, all
the methyl donor pathway precursors were being used due to this “deficiency” (Figure
12). For the egg consumption, since choline is more bioavailable that was the source of
the methyl donor. While in the choline bitartrate supplement period, an increase in dietary
folate and betaine was observed which could contribute to the methyl donor pathway, but
it was still probably not enough to see similar change in methionine as in the eggs.
Additionally, these individuals has normal kidney function, which can be a factor in
accumulation of TMAO and increase in plasma TMAO187. Notably, the interindividual
variation in plasma TMAO is very large 6,182. In this current study, participants are
characterized as having low fasting plasma TMAO concentrations in comparison to
individuals with CVD phenotypes4. Clearly, in this intervention, egg intake increased
plasma choline and did not alter the concentrations of TMAO when compared to baseline
values or choline supplement.
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FIGURE 1. The role of choline in homocysteine metabolism. Box: structure of phosphatidylcholine

FIGUREof choline
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tions in healthy subjects are unknown. Therefore, we investigated the effect of supplementation with choline (as phosphatidylcholine) on fasting and postmethionine-loading plasma
concentrations of homocysteine in healthy men.

Study design
In this double-blind, placebo-controlled, crossover study, the
subjects were randomly assigned to 1 of 2 treatment orders.
Randomization was stratified by plasma tHcy concentrations at
screening and by smoking habits. Thirteen subjects began phosphatidylcholine treatment, and the other 13 began placebo treatment, both for 2 wk. After a 2-wk washout period, the treatments
were reversed. Treatments consisted of ingestion of 34.0 g of a

The role of choline from egg consumption (white) and choline bitartrate (black)
SUBJECTS AND METHODS
supplementation
in homocysteine pathway and TMAO formation when comparing

Subjects
Subjects were recruited from the pool of volunteers registered

changes
from
baseline
toforend
each
intervention
(adapted from Olthof et al. 2005)183
at the
Netherlands
Organisation
Appliedof
Scientific
Research
TABLE 1
(TNO) Quality of Life (Zeist, Netherlands) and by advertisements in local newspapers. Eligible volunteers were healthy as
assessed by physical examination, a general health and lifestyle
questionnaire, blood pressure measurement, routine clinical laboratory tests, and blood analyses of tHcy and B vitamins. Plasma
tHcy concentrations were 26 mol/L. Volunteers had no history of CVD and had not used vitamin B supplements, lecithin,
or supplements containing choline, choline derivatives, or betaine 1 time/wk during the month preceding screening.
Of 48 eligible men, 26 men aged 50 –71 y with the highest
plasma tHcy concentrations (range: 11.0 –23.1 mol/L) were
included in this study. Subject characteristics are shown in Table
1. All subjects completed the study.
Written informed consent was obtained from all subjects. The
study was conducted according to Good Clinical Practice guide4 The local medical ethics committee
lines at TNO Quality of Life.
approved the protocol.

Subject characteristics at screening1
Value
Age (y)
BMI (kg/m2)
tHcy ( mol/L)
Vitamin B-6 (nmol/L)
Vitamin B-12 (pmol/L)
Folate (nmol/L)
ALP (U/L)
ALT (U/L)
AST (U/L)
-GT (U/L)
Creatinine ( mol/L)

61
27.7
14.7
64
236
11.7
73
21
21
25.7
88

6
2.2
3.4
44
61
3.9
16
8
6
11.0
11

Another reason for not observing change in fasting plasma TMAO is the fact that these
are healthy young adults. Elevated plasma TMAO has been correlated to CVD risk in
population prone to a cardiovascular events, such as coronary artery disease and
1
All values are x SD; n 26. All measurements in blood were taken
after an overnight fast. tHcy, total homocysteine; ALP, alkaline phosphatase;
ALT, alanine aminotransferase; AST, aspartate aminotransferase; GT, glutamyltransferase.

myocardial infarction . Furthermore, TMAO can be converted back to TMA by TMAO
reductase188, and TMA can be cleared by the kidneys137, particularly in this study, the
Downloaded from https://academic.oup.com/ajcn/article-abstract/82/1/111/4863306
by University of Connecticut Health Center - L.M. Stowe Library - Collection Management user
on 22 August 2018

participants had normal creatinine levels throughout the intervention which is a marker
for normal renal function. Nevertheless, TMAO/TMA can be cleared by the kidney and
not accumulate or circulate throughout the body187. Additionally, the interindividual
composition of the gut microbiota as well as FMO3 activity can be a contributor factor to
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TMAO plasma levels48. As observed in this study (Figure 10), according to previously
shown145, there is also an intraindividual variability in response to egg consumption. Only
14% of choline consumed as phosphatidylcholine, as it is in eggs, is metabolized to
TMAO145. Overall, this study confirms that when the same amount of dietary choline is
consumed, it is more bioavailable in eggs compared to choline bitartrate supplementation.

5.4.2. Gene expression – TMAO metabolism
Plasma TMAO has been shown to increase expression of scavenger receptors
responsible for uptake of modified LDL, therefore the reasoning for measuring gene
expression of one of these receptors. All though TMAO was measured in the fasted state,
it was expected to observe an increase in expression of these receptors145. CD36 did not
increase as expected with the choline bitartrate supplement intake in comparison to egg
consumption. A possible explanation to this phenomenon is that since there is no increase
in FMO3 expression, which is the main enzyme responsible for the conversion of TMA to
TMAO129, no change in plasma TMAO is observed when comparing egg intake and
choline bitartrate supplement. In addition, these are healthy adults as documented by
their baseline biochemical parameters. Therefore, if TMAO is not elevated in plasma
consequently expression of CD36 will not be increased in order to promote the uptake of
modified LDL and further progress into plaque formation.

5.5. Strengths and Limitations
Since this is the first dietary intervention comparing egg intake versus a dietary
supplement, the ideal scenario was to first investigate the effects in healthy individuals.
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In that case, the results for thus populations is known before investigating the effects of
such intervention in other participants at higher risk for CVD. Another strength of this
study was controlling renal function throughout the intervention as kidney clearance can
be a confounding factor in plasma TMAO analysis and data interpretation.

One limitation from our study could be the length on the intervention in order to reach that
threshold, if there is one, for increases in plasma TMAO between these two treatments.
Since there is a high interindividual variability of plasma TMAO 145, this could have also
played a role in the analysis. Even though a good number of subjects was used for this
intervention, when separating participants by high and low TMAO producers and number
was small to detect significance. Another confounding factor is the variance in gut
microbiota among individuals189 and in this study no fecal samples were collected for
characterization of the microbiota species. Collection of fecal samples would allow
identification of gut bacteria responsible for the conversion of choline to TMA in the
colon130. Another limitation is collecting fasting plasma, which could mean the peak of
plasma TMAO was missed for this intervention, but goal was to evaluate the long effect
of accumulating plasma TMAO as it has been seen in CVD risk population. Lastly, a great
limitation is using PBMCs for gene expression as FMO3 is highly expressed in the liver 129.
Therefore, a more representative sample would help understand the metabolism and role
of FMO3 in regard to different sources of dietary choline.
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5.6. Conclusions
Overall, despite what has been previously shown as egg intake increasing plasma TMAO,
these data show that it was not true. Eggs have dietary choline, but it does not increase
circulating plasma TMAO in healthy individuals. In fact, it is a great source of dietary
choline and many other nutrients. With that, it is safe to say that eggs may be incorporated
in the diet to meet the adequate intake of choline, an essential nutrient.
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Chapter 6: Conclusion and Future Directions
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For decades, egg consumption has been a controversial food because of its high
cholesterol, saturated fat and recently, choline content. Therefore, much research has
been done to explore the effects of egg intake in risk for CVD, especially populations of
concern such as metabolic syndrome, diabetic and chronic renal disease people. Now
with the emerging interest in the plasma TMAO as a predictor and factor in CVD risk 4,
and eggs having high dietary choline, a known precursor for TMAO formation, more
research is needed to investigate the effects of this rich and affordable food. Since not
many studies have compared different sources of dietary choline and formation of TMAO,
this was a novel trial, and it sets up the stage to many other studies to come.

The results from this study confirmed the hypothesis that egg intake did not increase risk
for CVD in healthy young adults. Importantly, biomarkers of CVD risk were improved with
egg intake such as HDL-C and HDL functionality. Additionally, intake of three eggs per
day resulted in higher intake of nutrients present in eggs, including vitamin E, selenium,
lutein and zeaxanthin in comparison to choline bitartrate supplement consumption.
Plasma choline concentrations were increased with egg intake without affecting plasma
TMAO, which contributes to the importance that choline has in biological functions. Egg
consumption also regulated cholesterol biosynthesis pathway in order to maintain a
balance between exogenous and endogenous cholesterol without raising LDL-C/HDL-C
ratio, an important biomarker of CVD. Unfortunately, the hypothesis that choline bitartrate
supplement intake would increase plasma TMAO was not supported, and further research
is needed in the field.
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Considering the results here obtained, as well as the limitations mentioned throughout
the chapters, the next step would be evaluating the effects of these treatments in a
population at risk. Investigating the effects of egg consumption in comparison to choline
bitartrate in metabolic syndrome and diabetics would be ideal. Since previous data with
egg intake in individuals with metabolic syndrome and diabetes have not raised risk for
CVD53,75, comparing to choline bitartrate supplementation would give great insight to the
formation of TMAO regarding both treatments. Another future direction would also be
collecting fecal and urine samples to evaluate the kinetics of TMAO formation and
clearance and relate that to dietary intake. It would be really interesting to see the effects
of postprandial intake of both treatments and TMAO formation to further understand the
metabolism of choline from dietary sources. Lastly, since FMO3 activity and phenotype
can be factored by gender and polymorphism, it would be interesting to see phenotype of
these individuals at higher risk for CVD and how TMAO formation would play a role in
increasing the risk.
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